Advisory Board (in alphabetical order)|
Richard Abbot (University of California, San Francisco, USA)
Alexander Brucker (University of Pennsylvania School of Medicine, USA)
David Chang (University of California, San Francisco, USA)
Jeffrey Liebman (Columbia University Medical Center, USA)
Frank Martin (University of Sydney, Australia)
Charles McGhee (University of Auckland, New Zealand)
Stephen Obstbaum (New York University Medical School, USA)
Jose Pulido (Mayo Clinic College of Medicine in Rochester, Minnesota, USA)
Donald Tan (Singapore National Eye Centre, Singapore)
Hugh Taylor (University of Melbourne, Australia)
Robert Weinreb (University of California, San Diego, USA)
Tien-Yin Wong (National University of Singapore, Singapore)
Kanxing Zhao (The First Affiliated Hospital of Nanjing Medical University, China)
Dennis Lam (Chinese University of Hong Kong, Hong Kong)
|Robert Ritch (New York Medical College, USA)
Yizhi Liu (Sun Yat-sen University, China)
Calvin Pang (The Chinese University of Hong Kong, Hong Kong)
Taraprasad Das (L V Prasad Eye Institute, Bhubaneswar campus, India)
Associate Editor (Asia-Pacific)
Jost Jonas (Medical Faculty Mannheim of the Ruprecht-Karls-University Heidelberg, Germany)
Associate Editor (International)
Dr Jorge Alio (University Miguel Hernandez de Elche, Spain)
Associate Editor (International)
Charles McGhee (University of Auckland, New Zealand)
Associate Editor (Asia-Pacific)
Jerry Shields (Thomas Jefferson University, Philadelphia, USA)
Associate Editor (International)
Ningli Wang (Beijing Tongren Hospital, China)
Associate Editor (Asia-Pacific)
Kang Zhang (University of California, San Diego, USA)
Associate Editor (International)
Shigeru Kinoshita (Kyoto Prefectural University of Medicine, Japan)
Associate Editor (Asia-Pacific)
Benny Chung-Ying Zee (Chinese University of Hong Kong, Hong Kong)
Orbit & Oculoplastcis|
Dr Tim Roberts University of Sydney, Australia
|Prof Yoon-Duck Kim|
Samsung Medical Center, Korea
|Prof Marie-Jose Tassignon|
Antwerp University, Faculty of Medicine, Belgium
|Prof David Tse|
Bascom Palmer Eye Institute in Miami, Florida, USA
|Dr Abhay Vasavada|
Raghudeep Eye Hospital, India
|Prof Chee-Chew Yip|
Khoo Teck Puat Hospital , Singapore
|Dr Ke Yao|
Second Affiliated Hospital Zhejiang University, China
|Dr Hunter Yuen|
Hong Kong Eye Hospital, Hong Kong
Cornea & External Eye Disease||
Prof Michael Belin University of Arizona , USA
|Dr Craig Donaldson|
Westmead Children’s Hospital, Australia
|Prof Kohji Nishida|
Osaka University Graduate School of Medicine, Japan
|Prof Marilyn Miller|
University of Illinois , USA
|Prof Lixin Xie|
Shandong Eye Institute, Qingdao, China
|Prof Kanwal Nischal|
University of Pittsburgh, UK
|Dr. Alvin Young|
Prince of Wales and Alice Ho Miu Ling Nethersole Hospitals, Hong Kong
|Dr Rita Sitorus|
Faculty of Medicine University of Indonesia, Indonesia
|Prof Makoto Araie|
University of Tokyo, Japan
|Prof Ronald Krueger|
Cole Eye Institute, Cleveland Clinic Foundation, USA
|Prof Tin Aung|
National University of Singapore
|Dr Michael Lawless|
Vision Eye Institute, Australia
|Prof Clement Tham|
The Chinese University of Hong Kong, Hong Kong
|Dr. Srinivas Rao|
Sri Ramachandra Medical University in Chennai, India
|Prof Xiulan Zhang|
Zhongshan Ophthalmic Center, China
|Prof Kazuo Tsubota|
Keio University School of Medicine, Japan
Retina - Medical|
Dr Carmen Chan Chinese University of Hong Kong, Hong Kong
|Prof Oh W Kwon|
Yonsei University, Korea
|Dr Jane W. Chan|
University of Arizona, USA
|Prof Chi-Chun Lai|
Chang Gung Memorial Hospital, Chinese Taipei
|Prof Satoshi Kashii|
Aichi Shukutoku University, Aichi, Japan
|Prof William Mieler|
University Illinois at Chicago
|Prof Andrew Lee|
The Methodist Hospital, USA
|Dr Tarun Sharma|
Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, India
Retina - Surgical|
Dr Neeru Gupta University of Toronto, Canada
|Prof Rajvardhan Azad|
Dr R.P. Centre for Ophthalmic Sciences, AIIMS, India
|Prof Christopher Leung|
The Chinese University of Hong Kong
|Prof Suber Huang|
Centre for Retina and Macular Disease of the University Hospitals Eye Institute, USA
|Prof Ki-Ho Park|
Seoul National University, Korea
|Prof Xiaoxin Li|
Peking University People’s Hospital, China
|Dr Dipika Patel|
University of Auckland, New Zealand
|Prof Marco Zarbin|
University Hospital in Newark, USA
Ocular Pathology & Oncology
Uveitis & Scleritis|
Dr. Bertil Damato Ocular Oncology Service in Liverpool, UK
|Dr. Timothy Lai|
The Chinese University of Hong Kong, Hong Kong
|Dr. Santosh Honavar|
Centre for Sight Superspeciality Eye Hospital, India
|Prof Narsing Rao|
University of Southern California, USA
|Prof Martine Jager|
Leiden University, The Netherlands
|Dr. Justine Smith|
Flinders University, Adelaide, Australia
|Dr. Tero Kivela|
University of Helsinki, Finland
|Prof Peizeng Yang|
Chongqing Medical University, China
Ophthalmic Epidemiology, Prevention of Blindness & Health Service Research
|Dr Nathan Congdon|
Queen's University, Belfast, Ireland
|Prof Jeffrey Boatright|
Emory University School of Medicine, USA
|Prof Mingguang He|
Zhongshan Ophthalmic Center, China
|Dr Teresa Borras|
University of North Carolina at Chapel Hill, USA
|Dr. Ivo Kocur|
|Prof Toru Nakazawa|
Tohoku University Graduate School of Medicine, Japan
|Dr Yuanbo Liang|
Wenzhou Medical University, China
|Dr Qingjiong Zhang|
Zhongshan Ophthalmic Center (ZOC), Sun Yat-sen University, China
Editorial Board Members (in alphabetical order)
Orbit & Oculoplastics|
Prof Soon-Phaik Chee Singapore National Eye Centre, Singapore
|Dr Kelvin Chong|
The Chinese University of Hong Kong, Hong Kong
|Prof Andrzej Grzybowski|
University of Warmia and Mazury, Olsztyn, Poland
|Dr Xianqun Fan|
Shanghai Ninth People’s Hospital, China
|Prof Xin Tang|
Tianjin Eye Hospital, China
|Prof Ashok Grover|
Sir Ganga Ram Hospital, India
|Prof Mingzhi Zhang|
ShantouUniversity/Chinese University of Hong Kong Joint Shantou International Eye Center, China
|Dr. Timothy Sullivan
Royal Brisbane and Women’s Hospital and Royal Children’s Hospital, Australia
Cornea & External Eye Disease
Prof Wei Chen Wenzhou Medical College, China
|Dr Sonal Farzavandi|
Singapore National Eye Centre, Singapore
|Dr Francis Price|
Price Vision Group, USA
|Dr A. S. Karthikeyan|
Regional Institute of Ophthalmology, Chennai, India
C-MER (Shenzhen) Dennis Lam Eye Hospital, China
|Dr Simon Ko|
Pamela Youde Nethersole Hospital, Hong Kong
|Dr Victoria Wong|
Hong Kong Eye Hospital, Hong Kong
|Dr Jason Yam|
The Chinese University of Hong Kong, Hong Kong
Dr Colin Clement Sydney Eye Hospital, Australia
|Dr John Chang|
Hong Kong Sanatorium and Hospital, Hong Kong
|Prof Jimmy Lai|
The Chinese University of Hong Kong, Hong Kong
|Dr Vishal Jhanji|
The Chinese University of Hong Kong, Hong Kong
|Dr Jacky Lee|
the University of Hong Kong and the Chinese University of Hong Kong, Hong Kong
|Prof Edward Manche|
Stanford University School of Medicine, USA
|Dr Seng Kheong Fang|
INTERNATIONAL SPECIALIST EYE CENTRE, Malaysia
|Prof Fengju Zhang|
Capital Medical University, China
Ophthalmic Epidemiology, Prevention of Blindness & Health Service Research||
Retina - Medical|
|Dr. Emmy Li|
Hong Kong Eye Hospital, Hong Kong
|Dr Marten Brelen|
The Chinese University of Hong Kong, Hong Kong
|Dr. Ravi Ravindran|
Aravind Eye Care System, India
|Prof Youxin Chen|
Peking Union Medical College Hospital, China
|Dr Nasir Saeed|
Pakistan Institute of Community Ophthalmology, Pakistan
|Dr Sudipta Das|
C-MER (Shenzhen) Dennis Lam Eye Hospital, China
|Prof Seang-Mei Saw|
National University of Singapore, Singapore
|Prof Toshinori Murata|
Shinshu University, Japan
Retina - Surgical|
|Dr Navin Jayakumar|
Darshan Eye Clinic, Chennai, India
|Prof Paul Chan|
University of Illinois, USA
|Dr. Michael Lee|
University of Minnesota, USA
|Prof Andrew Chang|
Sydney Eye Hospital, Australia
|Dr Sharon Tow|
Singapore National Eye Centre, Singapore
|Dr Wai-Ching Lam|
University of Toronto, Canada
|Dr Lin-Chung Woung|
Taipei City Hospital, Chinese Taipei
|Dr Vincent Lee|
Prince of Wales Hospital, Hong Kong
Uveitis & Scleritis|
|Prof Masanori Hangai|
Kyoto University Graduate School of Medicine, Japan
|Dr Xiaofeng Lin|
Zhongshan Ophthalmic Center, China
|Dr Shirley Liu|
Chinese University of Hong Kong, Hong Kong
|Prof Uwe Pleyer|
Humboldt University, Berlin, Germany
|Dr. Leopold Schmetterer|
Medical University of Vienna, Austria
|Dr Paisan Ruamviboonsuk|
Rajavithi Hospital, Bangkok, Thailand
|Dr Feng Wen|
Zhongshan Ophthalmic Center, China
|Dr Shwu-Jiuan Sheu|
Kaohsiung Veterans Hospital, Chinese Taipei
Ocular Pathology & Oncology||
|Dr Jyotirmay Biswas|
Sankara Nethralaya, Chennai, India
|Dr Dongfeng Chen|
Harvard Medical School, USA
|Prof Sarah Coupland|
Royal Liverpool University Hospital, UK
|Dr Fred Chen|
University of Western Australia, Australia
|Dr Bin Li|
Beijing Tongren Hospital
|Dr Lijia Chen|
Chinese University of Hong Kong
|Dr Ping Zhang|
Zhongshan Ophthalmic Center, China
|Dr Susumu Ishida|
Hokkaido University Graduate School of Medicine, Japan
Managing Editor: Florence Chung|
Editorial Assistant: Vicky Hui and Clare Mok
Richard ABBOTT, USA
Dr Abbott currently is the Thomas W. Boyden Health Sciences Professor of Clinical Ophthalmology at the University of California San Francisco and Research Associate at the Francis I. Proctor Foundation. Dr Abbott has served on the editorial boards of several ophthalmic journals and continues to lecture and publish on a variety of topics focusing primarily on corneal and external diseases of the eye, as well as quality of care, clinical practice guidelines, and medicolegal issues. He has authored or co-authored 88 publications and 32 book chapters and has delivered over 650 invited lectures and 20 named lectures. Dr Abbott has received numerous honors, including the prestigious U.S. President’s 25 year Volunteer Service Award, the International Golden Service Award from the Chinese Academy of Ophthalmology, the Jose Rizal Medal for International Service to the Asia Pacific region, the AE Maumenee Pan American Medal for Distinguished Service to Latin America, and the American Academy of Ophthalmology’s Lifetime Achievement Award. Dr Abbott is the immediate Past President of the American Academy of Ophthalmology and the Past President of both the Pan American Association of Ophthalmology and the Pan American Ophthalmological Foundation. Dr Abbott is a Board Director for the International Council of Ophthalmology and serves as Chairman of the Clinical Practice Guidelines Committee. He is a member of both the American Ophthalmological Society and Academia Ophthalmologica Internationalis.
Jorge ALIO, Spain
Dr. Jorge Alio has been professor and chairman of ophthalmology since 1987, first at the University ofAlicante and since 2002 at the University Miguel Hernandez de Elche, also in Alicante, Spain. Since the beginning of his professional career, he has been deeply involved in academic and research activities in combination with an intense clinical and surgical practice. His main dedication has been to cataract, cornea and refractive surgery, even though within his broader medical education he has been involved in other areas such as ocular inflammation (uveitis), vitreoretinal diseases and strabismus surgery. He has developed an academic career in different Spanish and international universities and has performed over 40,000 surgeries during his surgical career.
He has participated in the organization of many international and Spanish symposia and congresses, such as the International Ocular Inflammation Society, the European Society of Cataract and Refractive Surgery, the American Academy of Ophthalmology, the International Society of Refractive Surgery and the World Ophthalmology Congress, among many others.
He has been author or co-author of 440 peer-reviewed papers published in prestigious international scientific journals, 241 book chapters, 78 books (as editor or co-editor), over 200 collaborations in ophthalmic scientific journals and over 1800 presentations and invited lectures in international meetings. Dr. Alio's Hirsch factor (h-factor) that indicates the influence of his work in the publications of other researchers is 47 (Scopus), and he is listed with a field rating of 15 of top authors worldwide in ophthalmology during the past five years by the Microsoft Academic Search. At present, he holds the LXIII chair of the Academia Ophthalmologica Internationalis, XLIX chair of the European Academy of Ophthalmology and has received a total of 77 international and national awards.
Dr. Alio has directed a total of 56 PhD doctorate projects and is visiting professor of several European, Latin American and US universities. He participates in a number of executive boards and editorial boards of international scientific ophthalmological organizations. He has been a member-elect of the American Ophthalmological Society since 2013.
He is the founder of the foundation that bears his name, which is dedicated to promoting the prevention of blindness with actions both in Spain and on an international level, particularly in Mauritania where a Center for Sight is currently being created with the support of other international charitable organizations.
Makoto ARAIE, Japan
Affiliation: Director, Kanto Central Hospital, The Mutual Aid Association of Public School Teachers; Professor Emeritus, The University of Tokyo; Visiting Professor, Institute of Medical Science, Tokyo Medical University; Visiting Professor, Saitama Medical University. Area of Interest: Ocular blood flow, Normal tension glaucoma, Pharmacokinetics, Population-based study. Special honors: Suda Prize from Japan Glaucoma Society (1992); Alcon Research Institute's Award (1993); The Japan Ophthalmological Society Council Award (1999). The Japan Ophthalmological Society Award (2010). Leadership positions: Executive Committee Member of Glaucoma Research Society (2003-2008); President, Japanese Society for Ocular Pharmacology (2004-2006), Trustee, The Japanese Society of Ophthalmic Surgeons (2002-); President, Japan glaucoma Society (2006-); President, Japanese Ophthalmological Society (2007-2009); President, Asia-Oceanic Glaucoma Society (2007-), Council, Asia-Pacific Academy of Ophthalmology (2003-); President, World Glaucoma Association (2009-)of Academy; Editor-in-Chief, Folia Japonica de Ophthalmologica Clinica (2008-); Editorial Board, Japanese Journal of Ophthalmology (1996-); American Journal of Ophthalmology (2001-2004); Journal of Glaucoma (2006-).
Tin AUNG, Singapore
Tim Aung, Senior Consultant and Head, Glaucoma Service, Singapore National Eye Centre; Deputy Director, Singapore Eye Research Institute; Associate Professor, Department of Ophthalmology, National University of Singapore. A/Prof Aung is a clinician-scientist and leads the Glaucoma Research Group and the Ocular Genetics Group at the Singapore Eye Research Institute/SNEC. His main research interests are angle closure glaucoma and the molecular genetics of eye diseases. He has more than 220 publications, has been an Invited Lecturer to >70 International Conferences and has received numerous awards including the Singapore NMRC Clinician Scientist Awards in 2005 and 2008, the Nakajima Award from the Asia Pacific Academy of Ophthalmology in 2006 and the Singapore President’s Science Award in 2009. A/Prof Aung has more than US$15 million in competitive research grant funding and has set up collaborations with many centres worldwide in the US, UK, India, China, Myanmar, Thailand, Indonesia and Japan. A/Prof Aung is a member of the Editorial Board of Ophthalmology, Eye, Journal of Glaucoma, and 6 other journals.
Rajvardhan AZAD, India
Prof. Rajvardhan Azad, MBBS, MD (Ophth.), FRCSed, FAMS, FICS, Professor of Ophthalmology and Chief of Vitreoretinal & ROP Services at Dr R.P. Centre for Ophthalmic Sciences, AIIMS, is currently the Regional Secretary of Asia Pacific Academy of Ophthalmology and Secretary General of SAARC Academy of Ophthalmology. He is regarded and credited with shaping ophthalmic care and education in the Indian subcontinent. He was President of All India Ophthalmological Society and also Vitreo-Retinal Society of India. He is Fellow of Royal College of Surgeons Edinburgh, National Academy of Medical Sciences and International College of Surgeons. He is also Consultant for WHO, Sight Savers India, ORBIS International and Ministry of Health and Family Welfare, Government of India. He has major significant contribution in research in the field of ROP, Diabetic Retinopathy, AMD, Vascular Occlusion and other Retinal Diseases. He is Principal Investigators in more than 12 Multi Centre Global Clinical Trials and Chairman, Task Force and expert for Indian Council of Medical Research on various project related to retinal research. He has more than 200 publications in peer reviewed Journals, Authored 8 Books and has contributed Chapters in over 50 Books and periodicals. He is on Editorial Board and Reviewer of Indian Journal of Ophthalmology, Journal of Pediatric Ophthalmology & Strabismus, British Journal of Ophthalmology, Clinical & Experimental Journal of Ophthalmology, Journal of Ophthalmology World Journal of Eye Retina Vitreous, Acta Ophthalmologica and other periodicals. He has been honored with over 35 Awards and Orations. He has received awards by American Academy of Ophthalmology (Achievement Award), Asia Pacific Academy of Ophthalmology (De O’campo Oration for highest Academy Excellence in Asia Pacific Region) and All India Ophthalmological Society Dr P. Siva Reddy International Gold Medal and Dr C.N. Shroff Gold Medal for best retinal work in India besides felicitation like Life Time Achievement Award from many other societies.
Michael W. BELIN, USA|
Michael W. Belin, MD is Professor of Ophthalmology & Vision Science at the University of Arizona Department of Ophthalmology and Southern Arizona Veterans Administration Health Care System (Tucson, Arizona). He is also an Adjunct Professor of Ophthalmology at the Albany Medical College (Albany, New York) and University of Ottawa (Ottawa, Ontario). Dr. Belin is Past-President of the Cornea Society (2006-8) and currently serves a Vice-President for International Development. He is a Fellow of the Royal Australian & New Zealand College of Ophthalmology and serves on the Board of Directors, the Medical Advisory Board and the Executive Committee of the Eye Bank Association of America. Michael is also vice-chair of the American University Professors of Ophthalmology’s Fellowship Compliance Committee. Dr. Belin is a past recipient of the AAO Honor Award, Senior Honor Award, Achievment Award and a recipient of the AAO Life Time Achievment Award. He is the AAO’s representative to Australia and New Zealand and serves on the American Academy’s International Meetings Committee.
Jyotirmay BISWAS, India
Dr Jyotirmay Biswas is an ophthalmologist who has specialized in uveitis and ophthalmic pathology. He has done MBBS from Medical College, Calcutta and post graduation in ophthalmology from PGIMER, Chandigarh, and fellowship in vitreoretinal surgery from Sankara Nethralaya. He did two years fellowship in ophthalmic pathology from Doheny Eye Institute, University of Southern California, USA. He has published 264 articles in peer reviewed journals, 40 chapters in books of ophthalmology. He presented 29 papers in international conferences and 158 papers in national and state conferences. He had given 260 lectures in international and national conferences. He has received 26 awards which includes Hari OM Ashram award for clinical research from Medical Council of India. He is a member of International Uveitis Study Group and executive council member of International Ocular Inflammation Society. He was the first to describe ocular lesions in AIDS in India and published many articles. His current area of research is ocular tuberculosis, AIDS and Eales' disease. Currently he is working as director of uveitis and ophthalmic pathology departments at Sankara Nethralaya, Chennai. Dr Biswas also a marathon runner recites Bengali poems and writes Bengali articles and received many awards.
Jeffrey BOATRIGHT, USA
Jeffrey H. Boatright, PhD, Associate Professor of Ophthalmology, Emory University School of Medicine, is a graduate of Brown University (ScB in Neural Sciences and Experimental Psychology) and Emory University (PhD in Pharmacology and the Neurosciences Training Program). He joined the faculty of the Department of Ophthalmology in 1999, was promoted to Associate Professor in 2006, and is currently Director of the Redmond-Firman Center for Glaucoma Research at Emory University. Dr Boatright's initial research focused on the regulation of retinal gene expression funded by an independent R01 grant from the National Institutes of Health National Eye Institute (NIH NEI). This research expanded into using endogenous DNA repair mechanisms to treat genetic mutations that lead to blindness, a project also funded by an NEI R01. Recently develops in this project include using preconditioned tolerance to enhance endogenous DNA repair capability in the retina. In a separate project, Dr Boatright uses in vivo pharmacological approaches to explore the effects of atypical, endogenous compounds on animal models of retinal degeneration and glaucoma. This work is funded by the Katz Foundation, Foundation Fighting Blindness, NIH National Center for Complementary and Alternative Medicine (NIH NCCAM), and a Merit Award from the Veterans Administration in collaboration with Dr Machelle Pardue of the Atlanta VA Center of Excellence. Dr Boatright is Co-Principle Investigator on an NEI R24 and an NEI R01 whose aims include development of drug delivery to the posterior eye. He is also Co-Director of the Biochemistry and Molecular Biology Module of the Eye Center's NEI Core grant. Dr Boatright is founding and current editor-in-chief of Molecular Vision, a peer-reviewed online journal dedicated to the dissemination of research results in molecular biology, cell biology, and the genetics of the visual system. The journal is ranked in the top three in a field of 14 competing journals and is routinely used as an open access exemplar by the National Library of Medicine and The National Institutes of Health Library. The journal is co-sponsored by the Emory Eye Center and Zhongshan Ophthalmic Center of Sun Yat-sen University and is further supported by Knights Templar. Dr Boatright also serves on the editorial review boards of the International Journal of Molecular Sciences, International Ophthalmology Times, and Asia-Pacific Journal of Ophthalmology. Dr Boatright is the 2012 president of the Association for Research in Vision and Ophthalmology (ARVO), the premier vision research organization in the United States. He was named Silver Fellow of ARVO In 2010 and Gold Fellow in 2012, honors that recognize members for their accomplishments, leadership, and contributions to the Association. Dr Boatright also holds memberships in American Association for the Advancement of Science, the Society for Neuroscience, and the International Society for Eye Research.
Teresa BORRAS, USA
Dr Terete Borrás is an ocular molecular biologist with an interest in gene therapy. She received her Master degree in Biology from the University of Madrid, Spain and her Doctorate in Molecular Biology under a collaborative program of the University of Madrid and Purdue University, Indiana. She studied regulation of lens gene expression at the National Eye Institute (NIH) and led her laboratory to the identification of the mutation responsible for hereditary cataracts in an animal model. She directed the research division of an ophthalmic pharmaceutical company in Barcelona, Spain with an interest in glaucoma drugs. She is currently a Professor of Ophthalmology at the University of North Carolina at Chapel Hill. Dr Borrás is a member of the scientific advisory and editorial board of scientific association and has organized numerous national and international symposiums. She was the recipient of the “Jules and Doris Stein Professorship Award” from the Research to Prevent Blindness and the Association of International Glaucoma Societies (AIGS) Award for breakthrough in Glaucoma Research. Her research, funded by the National Institutes of Health, is mainly focused on the search for alternative, long-term treatments of glaucoma by the use of gene therapy. She has pioneered new strategies for delivering genes to the eye, and identified several candidate genes with good potential to reduce intraocular pressure. Her goals are to be able to provide the molecular basis onto which new efficient and safer gene/drugs for glaucoma could be developed.
Mårten BRELÉN, Hong Kong|
Dr. Mårten Brelén is an assistant professor at the Chinese University of Hong Kong (CUHK). He obtained his preclinical medical degree (MA) from Cambridge University, where he graduated with first class honors. His clinical medical degree (BMBCh) was obtained from Oxford University, and he also spent four years in research at the University of Louvain in Belgium, which led to a PhD in biomedical sciences. Clinically, Dr. Brelén is fellowship trained at the Bristol Eye Hospital, UK, in vitreoretinal surgery, and he is a fellow of the Royal College of Ophthalmologists, UK (London). Dr. Brelén is head of retina service at the CUKH Eye Centre and is the team head for the vitreoretinal service at the Prince of Wales Hospital. He is the lead coordinator of the clinical fellowship program for vitreoretinal training and the director of the Pao So Kok Macular Disease Treatment and Research Centre. He is also a visiting professor at the Joint Shantou International Eye Centre in Shantou, China.
Alexander BRUCKER, USA
Alexander Brucker was educated at the University of Maryland and received his M.D. degree at New York Medical College. After completing a residency at the Fridenwald Institute of Maryland General Hospital, he did a Fellowship in Diseases of the Retina and Vitreous under the mentorship of Dr Arnall Patz at The Wilmer Ophthalmologic Institute of the Johns Hopkins Hospital in Baltimore, Maryland.
In 1977, Dr Brucker relocated to the University of Pennsylvania School of Medicine where he was appointed to the faculty as Assistant Professor of Ophthalmology, and in 1994 became Professor of Ophthalmology, a position which he holds since that time. He served as Chief of the Retina and Vitreous Service at the Scheie Eye Institute/Department of Ophthalmology from 1979-1995.
During the course of his career, Dr Brucker has served in many leadership capacities, too numerous to list in this short biography, but a sample which is listed herein. He is a member of societies and organizations such as the Macula Society of which he served as President in 1992, the Retina Society, the American Society of Retina Specialists, Club Jules Gonin, and the American Uveitis Society. He served as Chairman of the Board of the Juvenile Diabetes Foundation of Philadelphia from 1987-90, holding other positions within that Foundation over the years.
Dr Brucker has received numerous awards which have acknowledged his leadership in education, research, and patient care. He has been honored by Philadelphia Magazine with “Best Doctors” on numerous occasions, has received the Golden Apple Award for outstanding teaching in the Department of Ophthalmology of the University of Pennsylvania on three occasions, was the recipient of the Albrecht von Graefe Award for distinguished contributions in ophthalmology by the American Society of Contemporary Ophthalmology, was the recipient of the Life Achievement Award from the Ophthalmic Club of Philadelphia, received the Life Achievement Honor Award from the American Academy of Ophthalmology, and was the recipient of the J. Donald M. Gass Medal by the Macula Society at its meeting in Phoenix, Arizona in 2010.
Dr Brucker has been invited to give numerous Named Lectureships throughout the world, some of which include the C.S. O’Brien Professorship Lecture at Tulane University, the Nachazel Lecture at William Beaumont Hospital, and the Albert C. Snell Memorial Lecture at the University of Rochester. Dr Brucker is the Editor-in-Chief of the foremost retina journal, RETINA, the Journal of Retinal and Vitreous Diseases, a position he has held and currently holds since 1981.
He is currently Editor of Retinal Cases and Brief Reports, and is Section Editor for the Asia-Pacific Journal of Ophthalmology. Dr Brucker has received innumerable invitations to be moderators of panels and honored guest lecturers locally as well as worldwide in such venues as Cape Town, Berlin, Sydney, Milan, Geneva, Bali, and Bangkok, just to name a few. He has authored over 100 papers which have been printed in prestigious peer-reviewed journals, and has been the author of published books, texts, and chapters, the list too large to mention.
His special interests have been the surgical treatment of vitreoretinal disorders, diabetic retinopathy, age-related macular degeneration, vascular occlusive diseases, and clinical trials to evaluate treatments for retinal diseases.
Dr Brucker has been Principal Investigator of multiple clinical trials including the Diabetes Control and Complications and Trial (DCCT), the Age-Related Eye Disease Study II, the MacTel Study, and a multitude of other randomized controlled trials of retinal and vitreous diseases. He has served as P.I. of two recent diabetic retinopathy trials sponsored by the DRCR.net of the National Eye Institute.
He has served on the Executive Committee of that organization. Dr Brucker has also served for seven years as a voting member of the Department of Food and Drug Administration’s (FDA) Ophthalmic Device Panel, an important regulatory panel for ophthalmology. Dr Brucker has been a role model for generations of medical students, residents, fellows, and colleagues, many of whom continue to contact him with regard to his expertise in the field of ophthalmology and specifically, diseases of the retina and vitreous.
Carmen CHAN, Hong Kong
Dr Carmen K M Chan, MB BChir (Cantab), MRCP(UK), MRCOphth, FRCSEd(Ophth), FCOphth (HK), FHKAM(Ophthalmology), graduated from the University of Cambridge with 1st class honours, and the University of London. She underwent training in internal medicine and ophthalmology in the UK before returning to Hong Kong to join the Department of Ophthalmology and Visual Sciences of the Chinese University of Hong Kong at the Hong Kong Eye Hospital (HKEH). Dr Chan subspecialises in Neuro-Ophthalmology and Uveitis. She received fellowship training in Neuro-ophthalmology under the mentorship of Prof Neil Miller at the Wilmer Eye Institute, Johns Hopkins University, US; and Prof J F Cullen at the Singapore National Eye Center. She is currently Associate Consultant, coordinator of the Neuro-ophthalmology Service and deputy coordinator of the Medical Retina and Uveitis service at the HKEH. She has published 40 papers in peer-reviewed journals and 2 book chapters. She has been on the Asia-Pacific Academy of Ophthalmology Congress scientific program committee (Neuro-ophthalmology) since 2008 and she is currently on the editorial advisory board of the Journal of Neuro-ophthalmology.
Jane CHAN, USA|
Dr. Jane Chan grew up in the San Francisco Bay area and graduated from the University of California, Berkeley. Her medical training began at Jefferson Medical College in Philadelphia and continued at the University of California, Davis for neurology residency. Dr. William F. Hoyt at the University of California, San Francisco inspired and trained her during fellowship to become an expert in neuro-ophthalmology.
Dr. Chan is presently a clinical professor in the Department of Neurology and Ophthalmology at the University of Arizona College of Medicine, Phoenix; Ruth Johnson Professor of Neuro-Ophthalmology; and Director of Neuro-Ophthalmology at the Barrow Neurological Institute, where she is involved in patient care, clinical research trials, teaching and publishing in major medical journals each year. In addition to serving on the editorial boards of major neurology and ophthalmology journals, Dr. Chan is a fellow of the American Academy of Neurology and the North American Neuro-ophthalmological Society.
Paul CHAN, USA|
R.V. Paul Chan, MD, is a professor and vice chair of Global Ophthalmology Programs for the Department of Ophthalmology and Visual Sciences at the Illinois Eye and Ear Infirmary at University of Illinois at Chicago. His clinical practice focuses on vitreoretinal surgery, with an expertise in pediatric retinal disease. Dr. Chan received his bachelor of arts from the University of Pennsylvania and medical degree from the Temple University School of Medicine. After completing an ophthalmology residency at New York Presbyterian Hospital, Weill Cornell Medical College, he went on to a fellowship in vitreoretinal surgery at the Massachusetts Eye and Ear Infirmary at Harvard Medical School.
Dr. Chan is an assistant editor for the journal Retina and remains active in a number of major ophthalmic societies as a member of the American Eye Study Club, the American Ophthalmological Society, the Retina Society, the Macula Society, the Association of Pediatric Retina Surgeons and the American Society of Retina Specialists. Dr. Chan is also an honorary member of the Thai Retina Society. He serves on the Global ONE Advisory Board and the Ethics Committee for the American Academy of Ophthalmology (AAO). He is also on the Executive Committee for the Pan-American Association of Ophthalmology.
Dr. Chan has won numerous awards including a Heed Ophthalmic Foundation Fellowship, the Ronald G. Michels Foundation Fellowship, the Paul Kayser International Fellowship, the Excellence in Ophthalmology Vision Award (XOVA), the American Society of Retina Specialists Senior Honor Award, the Achievement Award and two Secretariat Awards from the AAO.
David CHANG, USA |
A graduate of Harvard College and Harvard Medical School, David F. Chang, MD is clinical professor at the University of California, San Francisco and adjunct clinical professor at the Chinese University in Hong Kong. He previously chaired the ASCRS Cataract Clinical Committee and will serve as ASCRS president in 2012. Dr Chang is also Chairman of the AAO Cataract Preferred Practice Pattern Committee, immediate past chair of the AAO Practicing Ophthalmologist Curriculum Panel for Cataract/Anterior Segment, and in 2009 completed his 5-year term as chair of the AAO Annual Meeting program committee. He is a board member of the ASCRS Foundation and the Pan American Association of Ophthalmology and serves on the medical advisory board of three global humanitarian organizations (Himalayan Cataract Project, Help Me See, and Project Vision). Dr Chang is the chief medical editor of EyeWorld and was previously chief medical editor for Cataract and Refractive Surgery Today. Dr Chang has received the highest honor for cataract surgery from ASCRS (Binkhorst Medal), the AAO (Kelman Lecture), the Asia Pacific Association of Cataract & Refractive Surgery (Lim Medal), the United Kingdom and Ireland Society of Cataract & Refractive Surgery (Rayner Medal), the Canadian Society of Cataract and Refractive Surgery (Award of Excellence), the Indian Intraocular Implant & Refractive Society (Gold Medal), and the Italian Ophthalmological Society (Strampelli Medal). He has delivered keynote lectures for the Asia Pacific Academy of Ophthalmology, the Chinese Ophthalmological Society, and the Argentinean Society of Ophthalmology. In 2006, he became only the third ophthalmologist to ever receive the Charlotte Baer Award honoring the outstanding clinical faculty member at the UCSF Medical School.
Andrew CHANG, Australia|
Dr. Andrew Chang is a vitreoretinal subspecialist ophthalmologist. He graduated from University of Sydney Medical School with honors, then underwent registrar training at the Sydney Eye Hospital; Royal Victorian Eye and Ear Hospital; Manhattan Eye, Ear and Throat Hospital; and the University of California, Davis. He was awarded a doctor of philosophy for research into ocular retinal angiography performed in the US and at the Save Sight Institute, University of Sydney.
His current appointments include consultant vitreoretinal surgeon and head of the Retinal Unit at the Sydney Eye Hospital. He holds an academic appointment at the Save Sight Institute, University of Sydney, heading the Vitreoretinal Research Group. He is the medical director of Sydney Retina Clinic. Dr. Chang serves as a section editor for Clinical and Experimental Ophthalmology.
Dr. Chang's service to international ophthalmology includes his work as Scientific Secretary and founding committee member of the Asia-Pacific Vitreo-retina Society. He is the chair of the NSW RANZCO committee and councilor for Federal RANZCO.
Professional awards include the Asia-Pacific Academy of Ophthalmology Achievement Award and the RANZCO Teaching Award.
Dr. Chang is involved in basic science and clinical trials research receiving grant funding in Australia and the US. He has authored many peer-reviewed scientific papers in international and Australian journals and book chapters in leading textbooks.
John CHANG, Hong Kong|
Dr. John Chang was trained at Jules Stein Eye Institute, UCLA. He then went to USCF and did a fellowship there. He is a past president of the Hong Kong Association of Private Eye Surgeons. He is an honorary associate professor at the University of Hong Kong and the Chinese University of Hong Kong. He is presently director of the Guy Hugh Chan Refractive Surgery Centre at Hong Kong Sanatorium and Hospital and has been interested in cataract and refractive surgery for many years. He is a clinical instructor for many refractive intraocular lens procedures and surgeries including LASIK, intracorneal ring, conductive keratoplasty and phakic intraocular lens.
He is on the Executive Committee of the ISRS [American Academy of Ophthalmology (AAO)] and the APACRS. He is on the editorial board of Cataract and Refractive Surgery Today, EyeWorld (Asia edition) and Ocular Surgery News [Asia-Pacific Academy of Ophthalmology (APAO) edition] and is the chief editor of EuroTimes (China edition). He has also been awarded an APCRS Certified Educator Award, APAO Distinguished Service Award and AAO Achievement Award. Dr. Chang is also active in researching, publishing and traveling abroad to give lectures as an invited speaker to share his knowledge and findings.
Soon-Phaik CHEE, Singapore|
Dr. Chee is a senior consultant and heads both the Cataract Subspecialty Service and Ocular Inflammation and Immunology Service at the Singapore National Eye Centre. She is also the director for fellowships and a member of the Strategic Planning Committee at SNEC. She is a professor at the National University of Singapore and Duke-National University of Singapore Graduate Medical School and lead member of the cataract research team at the Singapore Eye Research Institute. She graduated from the National University of Singapore, obtained her master's there and became a fellow of the Royal College of Surgeons, Glasgow, Edinburgh and College of Ophthalmologists, UK. She did both her fellowships in uveitis and oculoplastics at Moorfields Eye Hospital, London.
She has published 200 peer-reviewed scientific papers and is a member of several editorial boards. She became an Asia Pacific Association of Cataract and Refractive Surgery Certified Educator in 2005 and received the American Academy of Ophthalmology Achievement Award in 2007. In 2011, she took on the position of Uveitis Chairman, International Council of Ophthalmology Residency Curriculum Update Project and is a member of the IOIS International Council. In 2013, she was appointed president of the Asia-Pacific Intraocular Inflammation Study Group.
Dong Feng CHEN, USA|
Dr Dong Feng Chen, M.D., Ph.D. is an Associate Professor at the Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School. Dr Chen's research focuses on mechanisms and application of neuroregenerative approach for retinal and CNS repair. Her lab is the first to demonstrate full-length optic nerve regeneration in post born mice, and moreover, discovering the molecules that can awaken the "sleeping" progenitor cells to repair the retina. These works hold a promise not only for restoring sight to people with retinal or optic nerve damage or diseases, but similarly to repair spinal cord or brain injuries. Dr Chen is a graduate of Beijing University, School of Medicine, and was trained in the laboratory of Nobel laurel Dr Susumu Tonegawa at the Massachusetts Institute of Technology before she joined the faculty at the Schepens Eye Research Institute and Harvard Medical School. She was featured on National Public Radio's "Talk of the Nation." She is an RPB Sybil B. Harrington Scholar and recipient of Outstanding Scientific Achievement Award from RP International.
Fred CHEN, Australia|
Fred Chen, MBBS (Hons), PhD, FRANZCO, is the director of clinical research at the Centre for Ophthalmology and Visual Science at the University of Western Australia. After completing vitreoretinal and medical retina fellowships at Moorfields Eye Hospital and receiving a PhD in retinal pigment epithelium transplantation at the University College of London, Dr. Chen returned to Perth to establish the Ocular Tissue Engineering Laboratory at the Lions Eye Institute. His clinical and research interests are in retinal imaging, image analysis, vitreoretinal surgery, clinical trials in dry age-related macular degeneration, management of retinal degeneration and stem cells.
Dr. Chen has published more than 80 papers in international peer-reviewed journals, co-authored 3 book chapters and delivered more than 20 invited lectures worldwide. He has received several awards and fellowships including the Global Ophthalmology Award (Bayer), an Early Career Fellowship Award (NH & MRC) and the New Independent Research Infrastructure Support Award (State Health Department).
Dr. Chen is a member of the American Society of Retinal Specialists and the Association for Research in Vision and Ophthalmology. He is a current board member of the Ophthalmic Research Institute of Australia, and he also serves on its grant review committee.
Li-Jia CHEN, Hong Kong|
Dr. Li-Jia Chen [PhD, Chinese University of Hong Kong (CUHK)] works as an assistant professor in the Department of Ophthalmology and Visual Sciences at CUHK and honorary associate professor at Shantou University Medical College. Dr. Chen's major research interests include genomic studies and gene mapping for glaucoma, age-related macular degeneration, high myopia and diabetic retinopathy, and molecular genetics, mechanisms and epigenetics of Graves ophthalmopathy, retinitis pigmentosa, uveitis and cornea dystrophies.
Dr. Chen is also an editorial board member of the journal Scientific Reports and is a reviewer for more than 10 international journals, including BMC Medical Genetics, Eye, Investigative Ophthalmology and Visual Science, Medicine, Molecular Vision, Ophthalmology, PLoS One, Retina and Scientific Reports. Dr. Chen has published more than 60 papers in SCI international indexed peer-reviewed journals.
Wei CHEN, China|
Dr. Wei Chen is a professor of ophthalmology and the head of Cornea Service at the affiliated eye hospital of Wenzhou Medical College in China. He graduated from Wenzhou Medical College with a medical degree in 1998 and from Shanghai Fudan University with a PhD in 2002. He was a postdoctoral research fellow at Schepens Eye Research Institute and in Dr. Stephen Pflugfelder's lab at Baylor.
He is an author of over 60 scientific research publications including 36 internationally peer-reviewed papers in journals such as AJO, IOVS, Cornea, BJO, etc. He has also served as reviewer for eight international journals in the field of ophthalmology and vision science including IOVS, BJO, Cornea, JCRS, etc. He is an advisory member of China Cornea Society and Asia Dry Eye Society. He has attracted over US $500,000 in grants and awards. He has experience of more than 1,500 cases of DALK, DSAEK and PKP. His clinical and research interests include the molecular mechanism and animal model of dry eye, corneal tissue engineering, corneal transplantation and prevention of cataract blindness.
Youxin CHEN, China|
As an ophthalmologist at Peking Union Medical College Hospital, Prof. Youxin Chen has done pioneering research on choroidal angiography in China. Photodynamic therapy and anti-VEGF therapy are also included in his area of expertise. Additionally, Prof. Chen has been actively engaged in clinical trials. The international multicenter clinical trials Brilliance Study, VIVID EAST Study and VEGF Trap-eye, in which Prof. Chen served as the principal investigator, achieved satisfactory outcomes. So far, Prof. Chen has published more than 50 articles in domestic and international journals, including Retina and IOVS. He also serves on the editorial board of many eye journals, such as the Chinese Journal of Ophthalmology and Chinese Journal of Ocular Fundus Diseases.
Currently, Prof. Chen has undertaken administrative responsibilities as the deputy director of the Department of Ophthalmology, Peking Union Medical College Hospital. He is also the general secretary of the ophthalmology branch of the Chinese Medical Association. For his efforts to promote the development of ophthalmology in China, Prof. Chen received the Distinguished Service Award from the Asia-Pacific Academy of Ophthalmology in 2008.
Kelvin CHONG, Hong Kong|
Dr Kelvin Chong is a surgeon-scientist in orbital and oculofacial surgery, and eye-related cell biology. He graduated at the top of his class in the Bachelor of Medicine and Surgery (CUHK) program. He was awarded the Li Po Chun Charitable Trust Fund Overseas Postgraduate Scholarship where he continued later as an international surgical and translational research fellow at the University of California at Los Angeles (UCLA) (preceptor: Prof. Robert Goldberg) and LA Biomedical Institute (Preceptor: Prof. Terry Smith and Dr Raymond Douglas). His awards included the City Lion Club Gold Medal, Action for Vision Eye Foundation Young Researcher of the Year, Exemplary Eye Resident Award, Achievement Awards from the American Academy of Ophthalmology and the Asia Pacific Academy of Ophthalmology. He has published more than 30 SCI indexed peer-reviewed articles and 4 book chapters.
Dr. Chong serves as the Coordinator of Oculoplastic Surgery at the Prince of Wales Hospital and the Associate Director of the CUHK Laser Refractive Surgery Center. He is the vice President of the Hong Kong Society of Ophthalmic Plastic and Reconstructive Surgery (HKSOPRS), Secretary of the Asia-Pacific Society of Ophthalmic Plastic and Reconstructive Surgery (APSOPRS) and council member of the College of Ophthalmologists of Hong Kong (COHK).
Colin CLEMENT, Australia|
Colin Clement received his Bachelor of Medicine and Bachelor of Surgery from the University of Sydney, Australia. He has also completed a Bachelor of Science (Honours) and PhD at the same institution. He undertook ophthalmology training at the Sydney Eye Hospital followed by glaucoma fellowship training in the UK and Switzerland. Dr Clement is currently a staff specialist in the glaucoma unit at Sydney Eye Hospital and a senior clinical lecturer at the University of Sydney. He chairs the associate advisory committee of the International Society of Glaucoma Surgery and is a member of the expert advisory committee for Glaucoma Australia. In addition, Colin is an associate editor for the Journal of Current Glaucoma Practice. He has clinical research interests in glaucoma surgery techniques and outcomes, and has authored 5 book chapters and more than 30 original research articles
Nathan CONGDON, China|
Dr Nathan Congdon received an AB degree from Princeton University and an MPhil from Cambridge, both in Oriental languages and literature. He is fluent in written and spoken mandarin Chinese and has maintained a life-long interest in Chinese culture, which he has chosen to pursue through medicine. His medical and public health education were received at Johns Hopkins University, where he pursued an ophthalmology residency at the Wilmer Eye Institute. Dr Congdon’s career has focused on public health research as a tool to improve the quality of blindness prevention programs in rural Asia. He has worked at the nexus between academia and program delivery. His research has resulted in the publication of over 100 peer-reviewed articles, and has been supported by the NIH, World Bank, RPB and the governments of China and Hong Kong. Dr Congdon moved with his family to China five years ago, where he is a Professor of Preventive Ophthalmology at Zhongshan Ophthalmic Center, the largest eye hospital in China. He regularly collaborates on blindness prevention programs in Asia and elsewhere with NGOs including Helen Keller International, ORBIS International and the Fred Hollows Foundation. In addition to providing medical and surgical care to adults and children with glaucoma, a major focus of Dr Congdon’s work has been the training of the next generation of eye doctors in China. He has received the Wilmer Resident Teaching Award, the Outstanding Service Award and Holmes Lecture Award from the APAO, and has recently been awarded a Thousand Man Prize by the Chinese government.
Sarah COUPLAND, UK|
Prof. Sarah Coupland is a senior pathologist at the Royal Liverpool University Hospital (RLBUHT) and the George Holt Chair of Pathology at the University of Liverpool (UoL). She is lead ophthalmic pathologist for the Liverpool Ocular Oncology Centre, which is a referral center receiving patients and tumor specimens from all over the world. She heads the successful Liverpool Ocular Oncology Research Group and has particular interests in the molecular genetics of melanomas and lymphomas. She is guardian of the Liverpool Ocular Oncology Biobank, which is a unique and precious resource of fully annotated ocular tumors and matched blood specimens.
Until April 2014, Prof. Coupland was also lead hematopathologist in the Liverpool-Merseyside Cheshire region, having established the hemato-oncological diagnostic service in September 2011. Further, she oversees the RLBUHT's molecular pathology service, which provides a broad repertoire of cytogenetic, DNA- and RNA-based molecular tests for cancer and noncancer diseases. Prof. Coupland is also director of the North West Cancer Research Centre - UoL and the University's Liverpool Tissue Bank, the oldest cancer biobank in the UK.
Prof. Coupland has extensive committee involvements both nationally and internationally: for example, president of the International Society of Ophthalmic Pathology (2011-present); immediate past president of the European Ophthalmic Oncology Group (2011-2014); and current Anatomy Pathology and Oncology Trustee of ARVO (2013-present). She has published about 200 scientific articles with an H-index of 41 (Google Scholar). Her current grant income totals £2 million as PI and £14 million as Co-I. The latter includes a recent Horizon2020 award involving a European Consortium examining metastatic uveal melanoma.
Bertil DAMATO, UK|
Professor Bertil Damato is Director of the Ocular Oncology Service in Liverpool. This service receives more than 700 new patients each year from all over the British Isles and from overseas. The main conditions treated include melanoma, metastasis, haemangioma and lymphoma. Therapies include plaque and proton beam radiotherapy, trans-scleral and trans-retinal local resection, various forms of phototherapy and topical chemotherapy. His main research interests relate to melanoma and include development and evaluation of novel therapies, genetic abnormalities, toxic tumour syndrome, and quality of life. He has published more than 160 peer-reviewed articles, several chapters and authored or co-authored textbooks. Professor Damato is President of the International Society of Ocular Oncology and Past President of the Ophthalmic Oncology Group and the European Vision and Eye Research Association.
Sudipta DAS, India|
Dr. Sudipta Das received an MBBS from Calcutta National Medical College, Kolkata in 2002. He did his MS (ophthalmology) at Vivekananda Institute of Medical Sciences, Kolkata in 2008 and worked as registrar in the same department until he began his fellowship in vitreoretinal diseases at Medical Research Foundation, a unit of Sankara Nethralaya in Chennai, in 2009. His fellowship in vitreoretina was from 2009-2011, and he was judged the best outgoing vitreoretinal fellow at Medical Research Foundation in 2011. He worked as an associate consultant at Sankara Nethralaya in the vitreoretinal department from 2011 to 2015 and currently works as senior overseas faculty in the vitreoretinal department at C-MER (Shenzhen) Dennis Lam Eye Hospital.
Dr. Das has several peer-reviewed publications to his credit. He has also presented at several national and international conferences. He is a member of the All India Ophthalmological Society, Vitreoretinal Society of India, Delhi Ophthalmological Society and West Bengal Ophthalmological Society. His special interests include surgery for retinal detachment, diabetic retinopathy and combined procedures involving both anterior and posterior segments. He is also actively involved in teaching and training vitreoretinal fellows at Sankara Nethralaya.
Taraprasad DAS, India|
Dr Das is currently Director of the L V Prasad Eye Institute, Bhubaneswar campus in India and Adjunct Professor of Ophthalmology in University of Rochester Medical School, Rochester, NY, USA. Trained in medical and surgical management of vitreo retinal diseases he has received ten research grants and has led or currently leading a number of research programs in diabetic retinopathy and age-related macular degeneration. He also has active clinical and research interest in infective endophthalmitis. He has published 142 papers, 27 book chapters and has authored or edited 6 books. He has given more than 300 lectures in the country and abroad. The leadership positions of Dr Das currently include: Vice President, Asia Pacific Vitreo Retinal Society; Member, Research Committee, Asia Pacific Academy of Ophthalmology; Associate Editor, Asia Pacific Journal of Ophthalmology; Convenor, National Board of examinations Specialty Advisory Board (Ophthalmology), Government of India; Member, Board of Studies in Ophthalmology, KIIT University; and Secretary of Vision 2020, India. He is also former President of All India Ophthalmological Society and Vitreo Retinal Society of India. The Indian Journal of Ophthalmology celebrated the golden jubilee while he was the Editor-in-Chief of the journal. Dr Das has delivered seven named lectures, has received fifteen awards from state and national societies (1993- 2009) in India, from the Asia Pacific Academy of Ophthalmology (APAO, 2006) and the American Academy of Ophthalmology (AAO, 2003). He was conferred Doctorate of Science (Honaris Causa) by the Raveshaw University in year 2011.
Craig DONALDSON, Australia|
Dr Craig Donaldson, MBBS, FRANZCO, FRACS. Fellow of the Royal Australian and New Zealand College of Ophthalmologists (RANZCO) and the Royal Australian College of Surgeons (RACS). Fellowship in Paediatric Ophthalmology and Strabismus at The Hospital for Sick Children, Toronto, Canada. The 1997 John Gaby Prize in Research, presented by The University of Toronto.Staff Specialist Westmead Children’s Hospital and Visiting Medical Officer at Sydney Eye Hospital and Sydney Children’s Hospital. Secretary of the Australian and New Zealand Strabismus Society. Senior member scientific programme committee RANZCO annual conference. Pacific Region Co-ordinator of the scientific programme for Paediatric Ophthalmology and Strabismus for the Asia Pacific Academy of Ophthalmology Annual conference. Supervisor of Fellowship training programme at Westmead Children’s Hospital Westmead. RANZCO councilor 2001-2006. Secretary NSW Branch RANZCO 2001-2006. Australian Orthoptic Board member 2000 until present.
Xianqun FAN, China|
Dr. Xianqun Fan is an ophthalmic plastic and orbital disease surgeon and an ophthalmic-related scientist. He is a leader in the Ophthalmic Plastic and Orbital Disease group of the Chinese Ophthalmological Society, Chinese Medical Association and a standing committee member of the Chinese Ophthalmological Society (2010-present). He was vice president (2006-2008) and then president (2008-2010) of the Asia-Pacific Society of Ophthalmic Plastic and Reconstructive Surgery.
His awards include the Second Award of the National Science and Technology Progress Award (The State Council, 2015), the First Award of Science and Technology Progress from the Science and Technology Progress Awards Jury (Ministry of Education of China, 2014) and the First Award of Shanghai Science and Technology Progress from the Science and Technology Progress Awards Jury (Shanghai Municipal Government, 2014). He has published more than 90 SCI indexed peer-reviewed articles and 28 books.
Dr. Fan serves as a professor in the Department of Ophthalmology, Shanghai Ninth People's Hospital (SJTUSM). He is president of the Institute of Ophthalmology and Visual Science at SJTUSM, a Distinguished Professor of SJTU and a Chang Jiang Scholar of the Ministry of Education of the People's Republic of China.
Ashok GROVER, India|
Dr A. K. Grover, Chairman, department of Ophthalmology, Sir Ganga Ram Hospital, New Delhi is the recipient of the prestigious National award of Padma Shri by the President of India. Dr Grover is the President of the All India Ophthalmological Society (AIOS), a board member of the Afro Asian Academy of Ophthalmology and Councillor at large of the Asia Pacific Academy of Ophthalmology. (APAO). Dr Grover is the past president of Oculoplastics Association of India, and vice President of the Asia Pacific Society of Oculoplastic and Reconstructive Surgery (APSOPRS). Dr Grover is the recipient of the prestigious Col. Rangachari Award for the best paper presented at the AIOS. He has been awarded an honorary FRCS, honorary Fellowship of the International Council of Ophthalmology (FICO) and of the International Medical Science Academy (FIMSA) He has been awarded distinguished service award by the APAO and has received named orations from most regional, state and subspecialty societies in India. Dr Grover has been invited to conduct courses or deliver guest lectures at the WOC, AAO, APAO, APSOPRS and the Afro Asian Congress. He has over 75 publications, 50 chapters and over 900 National and International presentations.
Andrzej GRZYBOWSKI, Poland|
Andrzej Grzybowski, MD, PhD, MBA, is a professor of ophthalmology and chair of the Department of Ophthalmology at University of Warmia and Mazury, Olsztyn, Poland, and head of the Department of Ophthalmology at Poznań City Hospital, Poland. His professional expertise includes cataract surgery, presbyopia treatment, clear-lens exchange, neuro-ophthalmology, vitreoretinal surgery, glaucoma pathogenesis, myopia pathogenesis, parameterizations in science and the history of ophthalmology.
He is active in international scientific societies including Euretina, AAO, ISBCS, ICO (also serving as program coordinator for WCO from 2011-2016), Cogan Society, EVER, ASCRS and represents Poland in the International Society of Refractive Surgery International Council (2015). For his research and other activities, he became a member of the European Academy of Ophthalmology.
He has delivered invited lectures at many national and international ophthalmic meetings, including in Italy, Spain, France, the UK, Germany, the US, India and South Africa. Prof. Grzybowski is on the editorial board of several international medical, ophthalmic and historical journals. He has been active editor, editor-in-chief and author of more than 300 peer-reviewed international publications (total IF higher than 550) and a reviewer for more than 20 journals
Neeru GUPTA, Canada|
Dr Neeru Gupta is Professor and Dorothy Pitts Chair of Ophthalmology & Vision Sciences at the Li Ka Shing Knowledge Institute of St. Michael's Hospital, University of Toronto. She is also Director of the Glaucoma and Nerve Protection Unit and appointed also to the Department of Laboratory Medicine and Pathobiology. Dr Gupta is the President of the Canadian Glaucoma Society, and a member of the Advisory Committee to the International Council of Ophthalmology. She is past Chair of the Glaucoma Section for the Association for Research in Vision and Ophthalmology and currently serves the Board of Directors of the American Glaucoma Society. Her research work is internationally recognized for groundbreaking investigations into visual system injury in glaucoma, and new insights into the outflow pathways of the eye.
Masanori HANGAI, Japan
Masanori Hangai, MD, PhD, graduated from Kyoto University School of Medicine, Kyoto, Japan, in 1990. He obtained his PhD in 1996 at the Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan. From 1997 to 2000, Dr Hangai was a Visiting Researcher and Visiting Assistant Professor at the Doheny Eye Institute, Department of Ophthalmology, University of Southern California, Los Angeles, CA. Since 2003, Dr Hangai has been a member of the faculty at the Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine; he is now an Associate Professor. His primary area of interest is retinal and glaucoma imaging using new optical imaging technologies such as spectral-domain optical coherence tomography (SD-OCT), swept source-OCT at 1050 nm, and adaptive optics-scanning laser ophthalmoscopy (AO-SLO). In his series of publications using prototype and commercially available SD-OCT instruments, Dr Hangai demonstrated that SD-OCT allows effective three-dimensional imaging and speckle noise-reduced imaging, both of which are extremely useful for diagnosis of various retinal diseases and glaucoma. With his young investigators, he is now studying photoreceptor and leukocyte imaging using prototype AO-SLO systems.
Mingguang HE, China
Prof Mingguang He is currently the Deputy Director and professor in Zhongshan Ophthalmic Center, Sun Yat-sen University in Guangzhou. He received his research training in Johns Hopkins University (MPH) and University College London (MSc and PhD). His research interest includes clinical and epidemiological research, randomized trial, twin study and imaging technology. He has published more than 70 papers in the international peer-reviewed journals and some important book chapters. He has given more than 30 invited lectures at Asia regional and international conferences. He serves as associate editor for Eye Science, editorial board member for Ophthalmology, International Review of Glaucoma and several Chinese ophthalmic journals. He has received several awards including a University College London Graduate Research Scholarship and Overseas Research Scholarship (2002), Top 3 and Top 10 best poster awards from the World Glaucoma Congress in Vienna (2005) and Singapore (2007), best paper presentation at the SEAGIG conference (2006) and distinguished young scholar award from the National Natural Science Foundation (2011)
Santosh HONAVAR, India|
Dr. Santosh G. Honavar completed his MBBS from Bangalore Medical College (Best Graduate of Bangalore University, 7 gold medals); postgraduate training in ophthalmology, followed by a fellowship in ophthalmic plastic surgery at the R. P. Center for Ophthalmic Sciences, AIIMS, New Delhi (Best Resident award); and fellowship in ocular oncology at Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.
His previous experience includes senior resident at AIIMS (1992-1995); faculty and head of the department, and later associate director of the L. V. Prasad Eye Institute, Hyderabad (1995-2013); and adjunct professor at the University of Rochester School of Medicine and Ohio State University Department of Ophthalmology.
Dr. Honavar focuses on tumors of the ocular surface, eyelid, eye and orbit, specifically retinoblastoma; eye plastic surgery; and eye prosthesis.
He has published extensively in peer-reviewed journals (over 150 manuscripts) and has written several book chapters. He is on the Advisory Board of the International Council of Ophthalmology. He is also secretary of the Oculoplastic Association of India and vice president of the Asia Pacific Society for Ocular Oncology and Pathology.
Some of the major awards and honors he has received include Pfizer National Award and Medallion; Col. Rangachari Gold Medal from the All India Ophthalmological Society (AIOS); Zeigler International Fellowship from Orbis International, USA; Dr. Siva Reddy International Award from AIOS; Senior Achievement Award from the American Academy of Ophthalmology; and the prestigious Shanti Swarup Bhatnagar Award from the government of India.
Suber S. HUANG, USA|
Suber S. Huang, MD, MBA received his undergraduate degree from the Johns Hopkins University, USA, his medical degree in 1985 from the Albert Einstein College of Medicine, USA and his MBA in 2004 from the Weatherhead School of Management, Case Western Reserve University, USA. He is certified by the American Board of Ophthalmology. He completed his ophthalmology residency training at the Wilmer Ophthalmological Institute, Johns Hopkins University and a fellowship in vitreoretinal diseases and surgery from the Bascom Palmer Eye Institute at the University of Miami, USA.
Dr. Huang joined the Department of Ophthalmology and Visual Sciences at University Hospitals of Cleveland, USA and Case Western Reserve University in 1993. In 1999, he founded the Retinal Diseases Image Analysis Reading Center at University Hospitals Case Medical Center. He served as Ophthalmology Residency Program Director from 2001-2003. Dr. Huang is currently Vice-Chairman, Director of Centre for Retina and Macular Disease of the University Hospitals Eye Institute and is Director of Ophthalmology Clinical Research Programs.
In 2010, Dr. Huang was elected President of the American Society of Retina Specialists (ASRS) and Chair of the Foundation of the ASRS. In 2012, he founded the ASRS Retinal Image Bank which has become the world’s largest and most comprehensive open-access repository of retinal images and video. He has served the American Academy of Ophthalmology on the Retina Sub-Specialty Program, the Ophthalmology Technology and Assessment Committee, and is the current Chair of the Research, Regulatory and External Scientific Affairs Committee. Since 2003, Dr. Huang has served on the Steering Committee for the National Eye Health Education Program, an advisory board to the National Eye Institute/National Institutes of Health. He is Chair of the Diabetic Eye Disease program and has a long-standing interest in the use of tele-ophthalmology for risk assessment of ocular complications of diabetes. Dr. Huang served on the Board of Directors for the Northeast Ohio Juvenile Diabetes Research Foundation from 2007-2010. He is a member of the Ophthalmology Leadership Advocacy Group, National Academies of Practice, Academy of Medicine, and American Academy of Ophthalmic Executives.
Dr. Huang served as faculty advisor for the Asian American Alliance from 1998-2009 and in 2008 he helped found Case for Sight, an undergraduate philanthropic organization dedicated to improving the lives of people with vision loss. He is a trustee of the University School and chair of the school’s Anderson Scholars Program in Cleveland, USA.
Dr. Huang has research interests in age-related macular degeneration, diabetic retinopathy, cell-based therapy, and retinal surgery. He is leading programs to develop novel diagnostic and surgical instrumentation, stem cell research and to implant the world’s first retina prosthesis, serves as a research consultant to industry, the National Eye Institute, and to NASA, and has given invited lectures worldwide. Dr. Huang’s honors include the achievement and senior honor awards from the American Academy of Ophthalmology and the American Society of Retina Specialists. He has been selected each year since 2003 to the Top Doctors in America, Northern Ohio Live and Cleveland Magazine Top Doctors award. In 2012, he received the Secretariat’s Award for contributions to the American Academy of Ophthalmology (AAO). In 2013, he was awarded the AAO Senior Honor Award, Rainbow Babies and Children’s hospital’s Pediatric Innovation Award, the J. Donald M. Gass award from the Ophthalmic Photographers Society, the Leadership Excellence Award from the National Diversity Council, was named Person of the Year by the Cleveland Sight Center, and was editor of his first book, Retina Images. He also received the Case Western Reserve University School of Medicine Health Care Foundation of New Jersey 2000 Humanism in Medicine award.
Susumu ISHIDA, Japan
Dr Ishida is a leading expert on retinal vascular diseases and is currently a professor of ophthalmology at Hokkaido University Graduate School of Medicine in Japan. After completing his medical degree in 1990, he undertook his residency in ophthalmology at Keio University School of Medicine. He completed fellowships in the Department of Ophthalmology at Keio University School of Medicine and the Massachusetts Eye and Ear Infirmary at Harvard Medical School. Dr Ishida’s research interests focus on the roles of VEGF in age-related macular degeneration and diabetic retinopathy. He is an author on over 100 scientific publications (impact factor: over 400) covering both clinical and basic studies. In 2009, he received the most honorable award from the Japanese Ophthalmological Society (JOS), called the JOS Council Award.
Martine JAGER, Netherlands|
Dr Martine J. Jager is head of the Laboratory of Ophthalmology at Leiden University, The Netherlands. She received her MD degree and PhD in immunology from Leiden University, did her residency in Ophthalmology at the University of Amsterdam, and a research and clinical Cornea and ocular surface disease fellowship at the Bascom Palmer Eye Institute in Miami. She is a frequent visitor at the Schepens Eye Research institute, Boston, where she holds a position as adjunct scientist. Her research interests are immunology and development of uveal melanoma, and ocular surface diseases, on which subjects she has published over 150 peer-reviewed papers as well as over 20 book chapters. She is reviewer for many ophthalmological journals, and is a member of the Editorial Board of Investigative Ophthalmology and Visual Science, among others. She mentors medical students (now over 75) and postdoctoral fellows (over 15), in the Netherlands as well as abroad. One of her self-appointed jobs is helping students to gain experience by studying in another country. She has lectured worldwide, and has been principal investigator on numerous grants dealing with the development and immunology of uveal melanoma. Many projects involve international collaborations. Dr Jager has served as President of the Association for Research in Vision and Ophthalmology (ARVO), is currently a Board member of the International Society of Ocular Oncology (ISOO), and of the European Association for Vision and Eye Research (EVER), Chairman of the Council of ARVO chapters, and is a member of the Advisory Board of the International Council of Ophthalmology. In 2011, she was elected member of the Academia Ophthalmologica Internationalis.
Navin JAYAKUMAR, India|
Dr Navin Jayakumar MBBS DO FRCSEd, Director, Darshan Eye Clinic, Chennai; Consultant, Vasan Eye Care Hospital, Chennai; Member, Editorial Board, Journal of Neuro-ophthalmology; Asia Co-ordinator for Neuro-ophthalmology, Scientific Program Committee, Asia-Pacific Academy of Ophthalmology. Dr Navin Jayakumar studied at Madras Medical College (1978-1984) and Regional Institute of Ophthalmology, Chennai (DO 1986-1988), and is a Fellow of the Royal College of Surgeons, Edinburgh (FRCSEd 2001). He trained in the superspeciality of neuro-ophthalmology at renowned centres in USA including Wilmer Eye Institute, Johns Hopkins Hospital, USA (1993-1994) with luminaries like Dr Neil Miller, Dr Joel Glazer, and Prof William Hoyt. He joined Sankara Nethralaya, Chennai in 1991 and was Head of Department of Neuro-ophthalmology at Sankara Nethralaya (2002-2005). In 2005 he was invited by The Chinese University of Hong Kong to help establish a Department of Neuro-Ophthalmology. He was also designated Honorary Professor of Ophthalmology at the Shantou Medical University, People’s Republic of China. During this period he also taught state-of-the-art cataract surgery aboard the Lifeline Express, a charitable eye hospital on wheels, in remote areas in China and was recognized by Hong Kong’s Action for Vision Foundation in 2006 for his work in alleviating cataract blindness there. Since 2008 he is also a visiting consultant at Vasan Eye Care Hospitals Chennai. Dr Navin Jayakumar was the Asia co-coordinator for Neuro-ophthalmology Symposium for the 2008 World Ophthalmology Congress, and is the Asia coordinator for Neuro-ophthalmology for the Asia Pacific Academy of Ophthalmology Meetings from 2009 till date. In 2010 January he became the first Indian to be invited to the Editorial Board of the premier scientific neuro-ophthamology journal in the world - the Journal of Neuro-ophthalmology.
Vishal JHANJI, Hong Kong|
Dr Vishal Jhanji is Assistant Professor in the Cornea and External Eye Diseases and Refractive Surgery Unit of the Department of Ophthalmology and Visual Sciences at the Chinese University of Hong Kong. He has co-pioneered new techniques of endothelial corneal transplantation during his fellowship in Australia. He has several publications to his credit in various international peer-reviewed journals. He has presented his scientific work in various international meetings and has won the best of show award at the annual meeting of the American Academy of Ophthalmology in the year 2008 and 2009. Dr Vishal is presently involved in research encompassing the fields of corneal surgery, novel techniques of corneal transplantation, prevention of corneal graft rejections, management of viral corneal infections, and refractive surgery.
Jost JONAS, Germany
Prof Jonas is currently Professor and Chairman of the Department of Ophthalmology of the Medical Faculty Mannheim of the Ruprecht-Karls-University Heidelberg in Germany. Prof. Jonas has research interests in the intravitreal application of medication as treatment of intraocular edematous, proliferative and neovascular diseases; the intravitreal cell-based drug therapy; the homologous intravitreal bone-marrow transplantation; the femtosecond laser assisted surgery of the cornea; the contact lens associated ophthalmodynamometry for measurement of the retinal arterial and venous blood pressure; the morphologic diagnosis of optic nerve diseases including the glaucomas; population-based studies (Beijing Eye Study; Central India Eye and Medical Study); and in Nanomedicine. Prof. Jonas is on the Editorial Board of several European ophthalmic journals. For his research, he became member of the German Academy of Science Leopoldina and the Glaucoma Society of the International Congress of Ophthalmology. He has received the Glaucoma Award of the German Ophthalmologic Society, the Junior and Senior Award of the American Academy of Ophthalmology, and the International Gold Awards of the Chinese Ophthalmologic Society. He is Fellow of the Association of Research in Vision and Ophthalmology ARVO.
Srinivas Kamalakara RAO, India
Dr Srinivas Kamalakara Rao, is currently Director of the Darshan Eye Clinic and Surgical Center, in Chennai, India. He also holds the post of Visitng Professor at the Sri Ramachandra Medical University in Chennai, and is Visiting Consultant at the Madras Medical Mission Hospital, Chennai, Sankara Eye Hospital, Chennai, and Sunetra Family Care Center, Kolkata. He is also Honorary Associate Professor at the Dept. of Ophthalmology, Chinese University of HK, and Visiting Professor, Shantou Medical University, PRC, and Professor at the Muthusamy Virtual University of Post Graduate Medicine. After completing his MBBS at the Madras University in 1989, he completed his Diploma in Ophthalmology at the Dr MGR Medical University in 1991, his National Boards in 2002, and passed the Fellowship of the Royal College of Edinburgh in 2002. He was awarded 4 gold medals for his performance in his MBBS exams and the Muthusamy Gold Medal for best performance in the FRCS exam. Dr Srinivas K Rao is an outstanding clinician and spent 15 years at the apex center for ophthalmic medicine in India – Sankara Nethralaya, in Chennai, India. He was Senior Consultant in the Cornea Service and was responsible for many firsts in the treatment of blinding corneal disorders in India. He introduced conjunctival autografts for pterygium surgery, limbal stem cell auto- and allografts for the treatment of limbal stem cell deficiencies. He also pioneered the use of osteo-odonto keratoprosthesis for the treatment of end-stage corneal blindness, and performed the first such procedure in India in 2003, with the help of Prof Falcinelli. Since then, he has performed the procedure for the first time in Hong Kong and China along with Professor Dennis Lam. Since his return to India in 2006, he has helped popularize and spread the concepts of lamellar corneal transplants for anterior and posterior corneal pathologies. He is currently involved in research projects involving the cultivation of cheek mucosal epithelial cells in a thermo-modulated gel, and endothelial cell cultures. He has over 175 peer-reviewed publications, mostly in the field of corneal diseases. He is a sought after speaker and teacher and has attended more than 150 national and 40 international meetings as faculty – in which he has presented more than 325 lectures. He is currently the Section Editor for Cornea, Clinical and Experimental OPhthalmology, reviewer for 10 international journals and has authored chapters in 19 books in Cornea and external diseases. He was awarded the APAO award for Prevention of Blindness in 2006, the IMA Oration in 2006, the Rustom Ranji Gold medal and Oration by the Andhra Pradesh Ophthalmic Society in 2008, the IAOH Oration in 2009, the APAO Special Achievement Award in 2011, and the MadanGopal Oration by the Vidharba Ophthalmic Society in 2011.
Satoshi KASHII, Japan
Sciences, Aichi Shukutoku University, Aichi, Japan.
Current research interests concern clinical research that addresses function, disease and response to therapy of neuro-ophthalmic disorders, with particular emphasis in visual fields and optic nerve disorders. Previous basic research concerned functional roles of the endogenous neurotransmitters in neuronal cell death and survival in the retina. Using cultured embryonic rat retinal neurons, he had demonstrated that neurotransmitters including modulators deliver not only neuronal signals but signals concerning cell survival or death. He is the Co-chair of the Ophthalmology Topic Advisory Group (TAG) for the International Classification of Diseases (ICD) at the World Health Organization and the Chair of the International Council of Ophthalmology Taskforce for ICD-11. As for social activities, Dr Kashii is the Secretary General of the Asian Neuro-Ophthalmology Society. He is the Co-editor-in-chief of the Japanese Journal of Ophthalmology, and an editorial board member of the Journal of Neuro-Ophthalmology, and the Neuro-Ophthalmology Japan. Dr Satoshi Kashii is Professor of Visual Sciences and Ophthalmology, Faculty of Health and Medical.
Seng Kheong FANG, Malaysia|
Dr Fang is Senior Consultant Ophthalmologist and Glaucoma specialist at the International Specialist Eye Centre in Kuala Lumpur, Malaysia. He graduated with an MBBS from the University Malaya, Kuala Lumpur in 1986. He obtained a Masters of Surgery in Ophthalmology at the National University of Malaysia in 1994. He was the Clinical Fellow in Glaucoma Department of Ophthalmology, Prince of Wales Hospital in Sydney under Dr Ivan Goldberg in 1995.
He was Consultant Ophthalmologist in Hospital Kuala Lumpur and headed the Glaucoma service between 1995 and 1999. Then he was Senior Consultant Ophthalmologist and Glaucoma Specialist at the Tun Hussein Onn National Eye Hospital from 1999 to May 2007.
Since 2012, he has served as Honorary Secretary of Asia Pacific Glaucoma Society. He has been President of Malaysian Society of Ophthalmology since 2013. Dr Fang was the recipient of the Distinguished Service award from APAOA (Asia Pacicfic Academy of Ophthalmology) in 2007 and the Asian Angle Closure Glaucoma Club in 2009. He has also been a member of the IMAGE Asia Pacific Glaucoma Advisory Board since its inception. He was elected Council member of the APAO in 2010 and was the Regional Secretary representing Malaysia. Since 2013, he has served as Chairman of the Young Ophthalmologist Standing Committee of the APAO. He has been a Board member of ASEAN Ophthalmology Society since 2013. He currently sits on the Editorial board of the International Glaucoma Review of the World Glaucoma Association, Asian Journal of Ophthalmology, Ophthalmic Surgery News APAO Edition and EyeWorld Asia Pacific.
Sonal FARZAVANDI, Singapore|
Dr. Sonal Kaizad Farzavandi (Gandhi) is a senior consultant in the Pediatric Ophthalmology and Strabismus Department at Singapore National Eye Centre. She received her MBBS degree from King Edward Memorial Hospital in Mumbai, India as a gold medalist with numerous gold medals and scholarships to her credit. She acquired the fellowship of the Royal College of Surgeons of Edinburgh in 1992.
Dr. Farzavandi is secretary-treasurer of the International Pediatric Ophthalmology and Strabismus Council and council member of the Asia-Pacific Society of Pediatric Ophthalmology and Strabismus. In addition, Dr. Farzavandi is a member of the American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, International Strabismological Association, European Strabismological Association, International Thyroid Eye Disease Society and Society for the Women in Ophthalmology.
Her clinical and research interests include pediatric strabismus and adult strabismus secondary to thyroid eye disease, nasopharyngeal carcinoma, trauma and vascular diseases. She has been invited to speak and conduct instruction courses on strabismus surgery both regionally and internationally. Her surgery is demonstrated in a surgical DVD included with the Color Atlas of Strabismus Surgery Strategies and Techniques by Dr. Kenneth Wright. In terms of surgical prowess, she has performed live surgery in Singapore and presented at the American Academy of Ophthalmology Pediatric Ophthalmology and Strabismus Sub-Specialty Day.
A.S. KARTHIKEYAN, India|
Dr. A. S. Karthikeyan is a specialist in pediatric ophthalmology, strabismus and ocular genetics. After completing his medical education at the world renowned Stanley Medical College, he pursued postgraduate work in ophthalmology at India's first and the world's second eye hospital, Regional Institute of Ophthalmology, Chennai. He received the "Best Resident" award.
Subsequently, he completed the "Diplomate of National Board" at the Aravind Eye Care System, one of India's and the world's leading eye care models. He came first (national level) and was awarded the Fellowship of National Board (FNB) in pediatric ophthalmology. He was awarded FRCS by the Royal College of Physicians and Surgeons of Glasgow. He established and developed the pediatric ophthalmology and neuro-ophthalmology services at Lumbini Eye Institute, Nepal. He has been trained at several world-renowned institutes (pediatric neuro-ophthalmology at Wilmer Eye Institute, Johns Hopkins; retinoblastoma at Birmingham Children's Hospital, UK; and ocular genetics at Wills Eye Institute).
He has been invited to speak at several national and international congresses. He has significant publications in peer-reviewed international journals. He has authored a book and several book chapters. He has international work experience and has contributed immensely to several eye care projects and programs in Nepal, India, Tibet, Tanzania and Cambodia.
Yoon Duck KIM, Korea|
Yoon Duck Kim. Education: Mar. 1973 - Feb. 1979: Graduated from College of Medicine, Seoul National University, Received M.D. Mar. 1981 - Feb. 1983: Graduated from Graduate School, Seoul National University, Received M.S. Mar. 1985 - Feb. 1991: Graduated from Graduate School, Seoul National University, Received Ph.D. Professional training: Mar. 1980 - Feb. 1983: Residency, Department of Ophthalmology, Seoul National University Hospital. Aug. 1986 - Jul. 1987: Clinical Fellowship of the Oculoplastic Surgery, Mt. Sinai Medical Center, Cleveland, Ohio, USA. Jul. 1992 - Dec. 1993: International Fellowship of the Oculoplastic Surgery, Jules Stein Eye Institute, UCLA, LA, CA, USA. Faculty appointment: Aug. 1989 - Aug. 1994: Chief, Division of Oculoplastic Surgery, Department of Ophthalmology, Seoul National University Hospital. Mar. 1994 - Present: Chief, Division of Oculoplastic Surgery, Department of Ophthalmology, Samsung Medical Center. Oct. 2000 – present: Editorial Committee, Korean Journal of Ophthalmology. Apr.2002 – present: Professor, Department of Ophthalmology, College of Medicine, Sungkyunkwan University. Mar. 2003 – Sept. 2009: Chairman, Department of Ophthalmology, School of Medicine, Sungkyunkwan University, Samsung Medical Center. Sept. 2003 – present: Editorial Board, Ophthalmic Surgery News. Sept. 2006- present: Editorial Board, Orbit. Mar. 2006 – March 2010: President, Korean Society of Ophthalmic Plastic and Reconstructive Surgery. June 2006 – June 2008: President, The Asia Pacific Society of Ophthalmic Plastic & Reconstuctive Surgery. Oct. 2008 - Oct. 2009 : Vice-president, The Korean Socity of Ophthalmology. Aug. 2009- present: Editorial Board, Ophthalmic Platstic and Reconstructive Surgery.
Shigeru KINOSHITA, Japan|
Dr Shigeru Kinoshita graduated from Osaka University Medical School in 1974, and has served as the Professor and Chairman of Ophthalmology at Kyoto Prefectural University of Medicine since 1992. In the early 1980s at Harvard Medical School, Dr. Kinoshita, in collaboration with Dr. Richard A. Thoft, established the concept of centripetal movement of corneal epithelium, and his groundbreaking work has shed new light on the importance of limbal epithelium. His series of findings has had an enormous impact on this subject and has afforded much insight, ultimately contributing to the development of the corneal stem cell theory set forth by Tuen-Tien Sun. Over the past 30 years, his primary interest has been focused on the research and development of new therapeutic modalities for the cornea. Following along this path, Dr. Kinoshita`s group has established the system of cultivated mucosal epithelial stem cell transplantation and cultivated corneal endothelial transplantation. His group has also proved the important role of mucosal epithelium on the ocular surface innate immunity. Dr. Kinoshita is a recipient of the 1999 Alcon Research Institute Award, the 2008 Castroviejo Medal Lecturer of the Cornea Society, and the 2011 Robert W. Doyne Lecturer at the Oxford Ophthalmological Congress. He served as the ARVO Trustee of the Cornea Section from 2006 to 2011.
Tero KIVELÄ, Finland|
Tero Kivelä, MD, FEBO, has been professor and chair of the Department of Ophthalmology, University of Helsinki, Finland since 2004 and director of its Ocular Oncology Service since 1995. He has made an international career in ophthalmic pathology and ocular oncology.
His participation in various organizations is as follows: founding member of the European Ophthalmic Oncology Group since 1991 and a board member and Secretary General from 1996-2002; member of the European Ophthalmic Pathology Society since 1994; founding member of the International Society of Ocular Oncology and member of its board from 2002-2011, general secretary from 2009-2011 and international liaison since 2012; and member of the Ocular Oncology Task Force of the American Joint Committee on Cancer.
Dr. Kivelä has held memberships in several international organizations promoting education and research in ophthalmology: the European Association for Vision and Eye Research from 2001-2011, as president in 2006 and program secretary from 2007-2011; European Board of Ophthalmology from 2001-2008, with vice presidency from 2001-2004 and presidency from 2005-2006; International Council of Ophthalmology from 2007-2014; European Academy of Ophthalmology since 2006; and Academia Ophthalmologica Internationalis since 2012.
Tak KO, Hong Kong|
Dr. Tak Chuen Ko is a specialist in pediatric ophthalmology, strabismus and general ophthalmology. He is the chief of service of the Ophthalmology Department at Pamela Youde Nethersole Hospital and Tung Wah Eastern Hospital in Hong Kong. Dr. Ko has been working in ophthalmology for 25 years, and he is actively involved in clinical research, teaching, training and examination of ophthalmology in Hong Kong. He is an author and co-author of publications in peer-reviewed journals.
Dr. Ko is currently serving on the council of the College of Ophthalmologists of Hong Kong and is past president of the Hong Kong Ophthalmological Association. Dr. Ko has also served in the Scientific Bureau of the World Society of Pediatric Ophthalmology and Strabismus. He received a Distinguished Service Award from the Asia-Pacific Academy of Ophthalmology in 2016 for his active contributions in meetings.
Ivo KOCUR, Czech Republic|
Dr. Ivo Kocur obtained his medical degree and advanced certification in ophthalmology in the Czech Republic, his native country. Before joining the World Health Organization (WHO), he practiced and taught at the Charles University Department of Ophthalmology in Prague, particularly in the area of vitreoretinal and inflammatory eye conditions; coordinated international eye care conferences, research and educational programs; and served as medical advisor for international eye care projects.
He coordinated the construction and activities of the Lions Ophthalmology Educational Center in Prague, an institution that serves many European countries through the provision of educational programs for eye care professionals, public health research and monitoring of eye care services. Dr. Kocur completed a master of science in community eye health at the University College London and a master of arts in diplomacy at the Diplomatic Academy of London, followed by a master of business administration at the European University in Geneva, Switzerland.
After joining the WHO prevention of blindness and deafness program, his responsibility was the coordination of the VISION 2020 Global Initiative "The Right to Sight," a major international partnership for the elimination of avoidable blindness. He has been involved in the development and implementation of three World Health Assembly resolutions on the prevention of avoidable blindness and two comprehensive global action plans for eye health, including the most recent one, "Universal eye health: a global action plan 2014-2019."
Dr. Kocur currently focuses on the implementation of the global eye health action plan in WHO member states; comprehensive national assessments of eye care services as part of national health systems; development of national plans and strategies for comprehensive eye care service delivery to children and adults, with emphasis on chronic age-related eye conditions such as cataract, diabetic retinopathy, glaucoma, selected retinal disorders, uncorrected refractive errors, provision of low vision care and rehabilitation; and systematic collection of global data on the status of eye care provision. He is also responsible for international collaboration in the area of eye care education and coordinates joint projects with WHO collaborating centers, international partners and leading global eye care professional organizations.
Ronald KRUEGER, USA
Dr Ronald R. Krueger, MD, MSE, is currently the Medical Director of the Department of Refractive Surgery at Cole Eye Institute, Cleveland Clinic Foundation. As a cornea trained specialist, he has performed fifteen thousand refractive surgery procedures and has been the principle investigator on 5 clinical trials. He has 24 years of experience in excimer laser research, including the first physical descriptions of the effects of the excimer lasers on corneal tissue, and many more developments, including the early principles of ocular wavefront customized laser vision correction. To this end, he has co-organized an international congress on Ocular Wavefront Customization for the past 8 years and co-authored the first book on the subject, "Customized Corneal Ablation: The Quest for Super-Vision", which was later followed by a second edition. He also has over 12 years research experience in ultra short pulse laser photodisruption of ocular tissue, and is involved in research investigating the cause(s) of presbyopia and restoration of accommodation with ultra short pulse lasers. He has authored over one hundred peer reviewed publications and many more abstracts, book chapters and trade journal articles. He is currently Co-Medical Lead for the concept OptoQuest, a Cleveland Clinic spin-off company and serves on multiple scientific advisory boards. He was the former Secretary of Education and board member of the ISRS prior to its merger with the AAO, and now serves in both the executive and program committees of the new ISRS/AAO. He has been Associate Editor for the Journal of Refractive Surgery for over 12 years, and has lectured on refractive surgery in over 40 nations. Dr Kruger received the American Academy of Ophthalmology Secretariat Award 2010; the Gold Medal Award, Indian Intraocular Implant & Refractive Surgery in 2010; Lans Distinguished Award by the ISRS/AAO in 2008; to name but a few. Dr Krueger has edited 4 books and has more than 25 book chapters to date.
Oh Woong KWOON, Korea|
Oh Woong Kwon is professor emeritus of Yonsei University. He is a vitreoretinal specialist and director of the Retina Center, Nune Eye Hospital, Seoul, South Korea. After graduating at the top of his class from Yonsei University Medical School, he trained as an intern/resident in ophthalmology at Yonsei University Medical Center and completed a vitreoretinal fellowship at Ohio State University Hospital, Ohio, USA. He obtained a master's degree from Yonsei University and a PhD from Inha University. His subspecialty is vitreoretinal service, including as an instructor, assistant professor, associate professor and professor of ophthalmology at Yonsei University.
His awards include Achievement Awards from Yonsei University Hospital, the American Academy of Ophthalmology, the Asia-Pacific Academy of Ophthalmology, the Korean Ophthalmological Society and the Korean Retina Society. In Korea, he serves as a council member (and former president) of the Korean Ophthalmological Society, the Korean Retina Society and the Korean Electrophysiology Society. Internationally, he is a council member of the Asia-Pacific Vitreo-retina Society and chair and representative of the International Committee of the Macula Society.
Prof. Kwon has published more than 47 SCI indexed peer-reviewed articles. He has published two books [Korean version: Retina (2014) and Macula (2015)] as the editor-in-chief and two books [English version: OCT (2012, Springer) and Retinal Pharmacotherapeutics (2015, Karger)] as a chapter author.
Chi-Chun LAI, Chinese Taipei|
Dr. Chi-Chun Lai is now a professor and chairman of ophthalmology at Chang Gung Memorial Hospital and Chang Gung University College of Medicine in Taiwan.
He graduated from Kaohsiung Medical University and did his residency at Chang Gung Memorial Hospital. His retinal fellowship was at Columbia University in New York with Prof. Stanley Chang. He was a retinal chief from 2003 to 2011, and then became vice chairman afterward.
He is currently vice president of the Asia-Pacific Vitreo-retina Society, council member of the Taiwan macular society and other local organizations. He is also a member of the Club Jules Gonin and The Macula Society. He has helped to organize important international meetings and actively participates in the activities of international societies.
His main interest is in macular disorders. He was the first investigator who used blood to assist internal limiting membrane (ILM) peeling and ILM repositioning with autoblood to repair MHRD in high myopia, and one of the pioneers in gene therapy for experimental choroidal neovascularization. He has published over 100 review articles, been an invited speaker at international meetings and served as an editor of scientific journals.
Jimmy LAI, Hong Kong|
Prof. Jimmy Lai graduated from the Faculty of Medicine at the University of Hong Kong in 1983. He joined the eye unit at the Prince of Wales Hospital in 1984, where he received his basic and higher surgical ophthalmology training. He spent six months at the Princess Alexandra Eye Pavilion, Edinburgh, for his higher surgical training in 1989. He obtained his fellowship and master's degree in 1990. He obtained the fellowship of the Academy (Ophthalmology) in 1993 and became a founding fellow of the College of Ophthalmologists of Hong Kong in 1995.
Prof. Lai continued his ophthalmology practice at the Prince of Wales Hospital, the teaching hospital of the Chinese University of Hong Kong. He received his prefellowship training at the Princess Alexandra Eye Pavilion, Edinburgh, and postfellowship training at the Massachusetts Eye and Ear Infirmary, Boston, and Aichi University, Nagoya, Japan. He became involved in scientific research and publications in the late '90s.
His subspecialty interest is glaucoma. He is a pioneer in applying argon laser peripheral iridoplasty as the initial treatment of acute angle closure glaucoma and acute phacomorphic glaucoma. With his work in this area, he obtained his doctor of medicine degree in 2004. He is also a pioneer in introducing selective laser trabeculoplasty and goniosynechialysis to Hong Kong for the treatment of open angle and closed angle glaucoma. Before he joined the Department of Ophthalmology at the University of Hong Kong in 2008, he worked at United Christian Hospital as a consultant ophthalmologist.
Timothy LAI, Hong Kong|
Dr Timothy Lai is an Associate Professor in the Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong. He is also a Visiting Professor of the Shantou University Medical College, China. His clinical and research interests lie in the management of macular diseases, particularly choroidal neovascularization, polypoidal choroidal vasculopathy, and central serous chorioretinopathy; visual electrophysiology; and genetics of retinal diseases. Dr Lai has published more than 140 papers in international peer-reviewed journals, co-authored and edited 7 textbooks and delivered more than 50 invited lectures worldwide. He has received a number of awards including the Nakajima Award of the Asia-Pacific Academy of Ophthalmology and Achievement Award of the American Academy of Ophthalmology. Dr Lai is a member of the Macula Society, the Retina Society and the American Society of Retinal Specialists. Dr Lai serves in the Editorial Boards of six ophthalmic journals, including Retina, Eye, and Clinical and Experimental Ophthalmology. He is also the Editor-in-Chief of the Hong Kong Journal of Ophthalmology, the Regional Secretary representing Hong Kong in the Asia-Pacific Academy of Ophthalmology, Scientific Secretary of the Asia-Pacific Vitreo-Retina Society, and an international council member representing China in the International Ocular Inflammation Society.
Dennis S.C. LAM, Hong Kong|
Prof. Lam has served as Chairman of the Department of Ophthalmology & Visual Sciences of the Chinese University of Hong Kong for over 13 years (1998-2011). He is a physician scientist with over 700 articles published in peer-reviewed journals. He serves in many eye journals: associate editor of “Clinical and Experimental Ophthalmology”, and editorial board member of “Journal of Cataract & Refractive Surgery”, “Acta Ophthalmologica”, “Japanese Journal of Ophthalmology” and “Chinese Journal of Ophthalmology”, etc. He is Chairman of Project Vision Foundation, Secretary-General of Asia-Pacific Academy of Ophthalmology (APAO) and Asia-Pacific Vitreoretina Society (APVRS), Council Member of World Glaucoma Association (WGA), and Asia-Pacific Association of Cataract and Refractive Surgery (APACRS). He was also Founding President of the Asia-Pacific Society of Eye Genetics (APSEG) (2002-8) and President and Organizing Committee Chairman of World Ophthalmology Congress (2008, Hong Kong). He was awardee of “De Ocampo Lecture (2003)” (APAO’s highest academic achievement award), “ICO Golden Apple Award (2011)” (Best Clinical Teacher in Ophthalmology in the Asia-Pacific region), “AAO Senior Achievement Award (2008)”, “Ten Outstanding Young Persons of the World (1995)”, and “Hong Kong Humanity Award (2007)”. Lastly, he is a Deputy of the National People’s Congress of China since 2008.
Wai-Ching LAM, Canada|
Dr Wai-Ching Lam is the Professor, Residency Program Director and the Continuing Education Director at the Department of Ophthalmology and Vision Sciences, University of Toronto. He is also the Retina Fellowship Director. He is the lead program director and chief examiner of ophthalmology section for the Center for the Evaluation of Health Professionals Educated Abroad for Ontario. Dr Lam is a vitreo-retinal surgeon and educator has published numerous peer-reviewed articles in Ophthalmology, Retina, British Journal of Ophthalmology, and Canadian Journal of Ophthalmology….etc. He has also authored 6 book chapters. He serves as the reviewer for Ophthalmology, Retina, Journal of AAPOS, British Journal of Ophthalmology, Canadian Journal of Ophthalmology, Journal of Rheumatology, Hong Kong Medical Journal…etc. He speaks frequently at both national and international meetings. He has been invited speaker, visiting professor, and meeting session chairman in many national and international meeting. He won numerous teaching awards from both the Faculty of Medicine and the Department of Ophthalmology. His main clinical interests are in adult and pediatric vitreoretinal diseases. In addition, he also published in the field of medical education, and recently the use surgical simulator in training and assessment.
Michael LAWLESS, Australia|
Dr Michael Lawless, MBBS, FRANZCO, FRACS, FRCOphth, is a recognised world authority in eye surgery. His specialty is laser vision correction, cataract and lens surgery, and corneal transplantation. He has performed over 20,000 surgical procedures in the following areas: LASIK and ASLA (Advanced Surface Laser Ablation, PRK), Refractive lensectomy, cataract and lens surgery (including phakic intraocular lens surgery), Corneal transplantation. Dr Lawless graduated in Medicine from the University of Sydney in 1980. Ophthalmology training in Sydney was followed by two years of sub-speciality education, a corneal and external diseases Fellowship with Professor Doug Coster in Adelaide, and a second Fellowship in corneal and refractive surgery with Professor Richard Troutman at the Manhattan Eye, Ear & Throat Hospital in New York. Career highlights: First Australian (and 3rd surgeon in the world) to perform cataract surgery with the femtosecond laser (LaserlensSMA) in Feb 2011; Performed the first LASIK procedure in Sydney in 1995; President, International Society of Refractive Surgery, 2001; Chairman, Department of Ophthalmology, Royal North Shore Hospital, 2000-2006; 60 publications in the peer reviewed scientific literature and 30 textbook chapters written on innovations in eye surgery. Selected to perform televised live surgery at international meetings, including the American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery and the Asia Pacific Academy of Ophthalmology. Awards: Cedric Cohen Medal for Excellence in the Royal Australian College of Ophthalmologists examination, 1982; Visiting Professor, University of Melbourne, 1998; Honour Award, American Academy of Ophthalmology for Services to Education in Ophthalmic Surgery, 1999; Founders Award from the International Society of Refractive Surgery, Chicago 2005; Invited Guest Lecturer to the world’s main scientific meetings, most recently the Asia Pacific Academy of Ophthalmology in Bali, 2009; the Taiwan Ophthalmological Society in May 2010; and the American Academy of Ophthalmology in Chicago, October 2010. And also: Consultant ophthalmologist to the Australian Defence Force; Consultant ophthalmologist to the NSW Rugby Union; Dr Lawless is married with three teenage children and is a Shodan (black belt) in Goju Ryu karate. He currently trains in Aikido.
Andrew LEE, USA|
Andrew G. Lee, M.D. is chair of the Department of Ophthalmology at The Methodist Hospital in Houston, Texas and is Professor of Ophthalmology, Neurology, and Neurosurgery at Weill Cornell Medical College. He is adjunct professor of Ophthalmology at the University of Iowa and at Baylor College of Medicine and a Clinical Professor at the University of Texas Medical Branch in Galveston, Texas. Dr Lee serves on the national and international Editorial Board of 12 journals including the American Journal of Ophthalmology, the Canadian Journal of Ophthalmology, the Japanese Journal of Ophthalmology, the Journal of Neuro-ophthalmology, and Eye and he has published over 280 peer-reviewed articles, 40 book chapters, and five full textbooks in ophthalmology. He has been the invited speaker at over 2oo national and international eye meetings.
Jacky LEE, Hong Kong|
Dr. Jacky Lee graduated with distinctions from the medical school at the University of Hong Kong. He is an honorary clinical assistant professor at both the University of Hong Kong and the Chinese University of Hong Kong. Dr. Lee was formerly an associate consultant in ophthalmology for the Hospital Authority, before his current private practice.
Dr. Lee has over 65 publications in international, peer-reviewed journals and has authored 10 book chapters. He is an academic editor of Medicine, editorial board member of the International Journal of Ophthalmology and Hong Kong Journal of Ophthalmology and a regular reviewer for 24 international medical journals.
Additionally, Dr. Lee was one of the world champions in the International Council of Ophthalmology knowledge competition. He has been awarded gold medals and research awards by various organizations including the Hong Kong Academy of Medicine, Hospital Authority and the Hong Kong Annual Scientific Meeting Ophthalmological Symposium committee.
He has presented clinical research, delivered invited lectures, taught instruction courses and chaired symposium sessions in a number of international conferences. He has secured grants that have helped introduce minimally invasive glaucoma surgeries to Hong Kong and was one of the first ophthalmologists in Hong Kong to be certified as a Trabectome trainer.
Michael LEE, USA|
Michael S. Lee, MD, is a professor of ophthalmology, neurology and neurosurgery and serves as the Residency Program Director in Ophthalmology at the University of Minnesota, where he holds the Mackall-Scheie Research Chair. He serves as director of the neuro-ophthalmology service and co-director of the Center for Thyroid Eye Disease at the University of Minnesota. He completed his medical degree and residency at the University of Pennsylvania School of Medicine. Dr. Lee finished his neuro-ophthalmology fellowship at the Massachusetts Eye and Ear Infirmary at Harvard Medical School, where he was awarded a Distinguished Teaching and Service Award.
Dr. Lee has over 120 peer-reviewed publications and serves on the Board of Directors of the North American Neuro-Ophthalmology Society. He has served on the editorial boards of three international ophthalmology journals and chairs the neuro-ophthalmology section of the Annual Meeting Program Committee for the American Academy of Ophthalmology.
Vincent Yau Wing LEE, Hong KongDr Vincent Lee is Consultant of the Department of Ophthalmology & Visual Sciences, Prince of Wales Hospital in Hong Kong. He is also the Honorary Clinical Assoicate Professor of the Department of Ophthalmology and Visual Sciences, Faculty of Medicine, the Chinese University of Hong Kong. He is the Coordinator of the Vitreo-retinal team at Prince of Wales Hospital and Alice Ho Miu Ling Nethersole Hospital. He has 1 US patent of an ophthalmic instrument and he has published more than 60 papers in international peer-reviewed journals. Research interests: 1. Ophthalmic surgery: Several surgical techniques was designed to perform surgery on difficult cataract cases which include cataract surgery combined with vitreous hemorrhage, soft cataract with deep anterior chamber and internal fixation for dropped intraocular lens. 2. Macular diseases: The clinical studies on various treatments on diabetic macular edema which include laser treatment, intravitreal steroid injection, intravitreal anti-VEGF injection and combined treatment.
Christopher LEUNG, Hong Kong
Dr Christopher Leung is Associate Professor of the Department of Ophthalmology & Visual Sciences, the Chinese University of Hong Kong (CUHK). He is a clinician-scientist with research focus on ocular imaging and glaucoma management. He received the Degree of Doctor of Medicine (CUHK) in 2006, 5 years after completing his undergraduate medical training. He was then awarded the Croucher Foundation Fellowship and completed a clinical and research fellowship program at the Hamilton Glaucoma Center of the University of California San Diego directed by Prof. Robert N. Weinreb. Among his research awards include Hong Kong Medical Association Prize, National Best Paper on Prevention of Blindness in the World Ophthalmology Congress 2006, Schanzlin Research Award, World Glaucoma Association Science Award – the Promise, American Academy of Ophthalmology Achievement Award, Association for Research in Vision and Ophthalmology /Alcon Clinician-Scientist Research Award, Asia Pacific Academy of Ophthalmology Nakajima Award and Asia Pacific Joint Glaucoma Congress Young Scientist Award. Dr Leung currently serves on the Associate Advisory Board of the World Glaucoma Association (WGA), the Editorial Board of Ophthalmic Surgery, Laser and Imaging, International Glaucoma Review, Journal of Ophthalmology, and Recent Patents on Medical Imaging, as co-chair of the WGA Clinician-Scientist Committee and reviewer of 25 peer-reviewed academic journals. Dr Leung has been senior instructor and invited speaker in various academic conferences including American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, and Asia-Pacific Academy of Ophthalmology Annual Meetings, World Ophthalmology Congress, World Glaucoma Congress, World Ophthalmology Leaders Forum in Education, and the Glaucoma Foundation Think Tank Meeting. Dr Leung has received research grant support from The Glaucoma Foundation (New York, NY, USA), American Health Assistance Foundation (Clarksburg, MD, USA) and the Food and Health Bureau (Hong Kong SAR Government.
Bin LI, China|
Professor Bin Li graduated from the Capital Medical University in 1982. As a visiting scholar, she went to Denmark Eye Pathology Institute to study Ophthalmic Pathology, and went to the Ophthalmology Department of Gentofter Hospital, Copenhagen University to conduct a clinical research project during 1992 - 1993.
She served as Deputy Director of the Beijing Tongren Eye Center Medical Office, Deputy Director of the Orbital Disease and Oncology Division, Director of BASIC department, and as a Committee Member of Beijing Academy of Ophthalmology Faculty Committee. At present, she is the Director of the Department of Ocular Pathology, Beijing Tongren Hospital, the Deputy Head of the Ophthalmology Pathology group of the Chinese Ophthalmology Society, and the member of APSOOP. She has engaged in ophthalmic clinical work for more than 30 years, and has demonstrated long-term commitment to specialized fields of ophthalmic tumors and ophthalmic pathology. Other clinical specialties include: ocular tumors, orbital disease and diagnosis and treatment for rare eye diseases; histopathologic diagnosis and consultation for ocular diseases; diagnosis by B ultrasound and ophthalmic imaging. Her research interests are clinical histopathologic features of Ocular tumor, basic research of molecular pathology and the related application research for proliferative mechanism.
She has published more than 30 SCI indexed peer-reviewed articles and 85 articles in prominent Chinese journals.
Emmy LI, Hong Kong|
Dr. Emmy Li graduated from the University of Hong Kong at the top of her class with distinctions in Medicine, Surgery and Pediatrics. She obtained a Master's degree in Public Health (with Distinction) in 2010. Since 2011, she has been working as a specialist in Ophthalmology at the Hong Kong Eye Hospital. Dr. Li serves as the Chairman of the Public Education Committee at the Hong Kong Federation of Societies for the Prevention of Blindness and as the Deputy Convenor (Ocular Epidemiology) of the Academic Committee at the Department of Ophthalmology and Visual Sciences, the Chinese University of Hong Kong. She is a reviewer of international peer-reviewed journals including the Archives of Ophthalmology, Journal of Cataract and Refractive Surgery, Expert Review of Ophthalmology, Asia-Pacific Journal of Ophthalmology and Ophthalmic Epidemiology.
Xiaoxin LI, China|
Xiaoxin Li is the Chairperson and Professor for the Eye Center and Eye Institute of Peking University People’s Hospital. She is an academic committee member of Peking University Health Science Center and former Dean of Ophthalmology Faculty of Peking University Science Center. She is currently Past President of the Chinese Ophthalmology Society (COS) and President of the Chinese Ocular Fundus Society (Vitreo-Retina Society). Last year she accepted the position of Director of Ophthalmology in the Health Human Resources Development Center and is in charge of the national evaluation exam for Ophthalmologists in China. She serves as a member of the AAO’s Global Advisors Committee since 2007 and is a board member of the International Council of Ophthalmology since 2010. Dr Li received the First and Second Prizes of the Chinese Ministry for Education in 2006 and 2008, Global Women Award of scientific and technological innovation in 2009, Song Qingling Children’s Prize in Medical Science in 2009. APAO Gold Apple Award in 2008 and COS Outstanding Achievement Award in 2008. She has contributed significantly to ophthalmic training and education, especially in the vitreo-retinal area in China. She has organized numerous VR lectures, seminars, workshops, and courses in the past two decades. She has been keen on writing books to provide better training materials. She edited the book
《Surgery on Vitreous and Retina》, and served as chapter editor for《Vitreous Diseases》，《Retina Diseases》《Retinal Detachment》and in many other ophthalmology books. As chief Editor she organized the translation for Retina. From 2011 she becomes Chief Editor of
《Chinese Journal of Ocular Fundus Diseases》， She has authored or co-authored more than 200 papers in Chinese and international Journals..
Yuanbo LIANG, Hong Kong |
Dr LIANG Yuanbo, MB (SEU), MSc (ZSU), MD(CMU), is an assistant professor in the Department of Ophthalmology and Visual Sciences. He received his residency training in the Zhongshan Ophthalmic Center and the Beijing Tongren Eye Center and was postdoctoral research fellow in Wilmer Eye Institute, Johns Hopkins University (USA). His major research areas are glaucoma and ocular epidemiology. Among his academic awards include the excellent graduate of Sun Yat-sen University (2002) and Capital Medical University (2007), the excellent paper award in the Congress of Chinese Ophthalmological Society in 2007, and the excellent resident award by the Chinese Ophthalmological Society (COS) in 2004 and 2005. He was the recipient of ARVO travel grant in 2008, Beijing New Star Program of Science and Technology (2009-2012), and APAO leadership program (2011-2012). Dr Liang is currently the member and the secretary of Sanding Committee of Blindness Prevention, Asia Pacific Association of Ophthalmology; and the secretary of Evidence Based Ophthalmology Group, Chinese Medical Doctor Association, and Youth Commissary of the Chinese Ophthalmological Society. Research interests: 1) Ophthalmic epidemiology. Dr Liang was project leader of the Handan Eye Study, a large scale population-based study conducted in Handan, North China providing important information for public health of eye care in China. Dr Liang now focuses his research on the diversity and influence of age of eye diseases, and community based intervention of avoidable blindness. 2) Clinical trials on glaucoma. Dr Liang leaded a survey to obtain a clear profile of the practice patterns of PACG management among ophthalmologists in mainland China. His team has conducted several clinical trials on PACG, including laser treatment strategy versus surgery, trabeculectomy with or with releasable suture, laser or observation for PACS, laser iridoplasty or iridotomy, and cost-effectiveness evaluations. He is also the project director of an ongoing 27-center participated RCT: The Initial Treatment Study of PACG (ITSPACG), which investigates whether trabeculectomy is an alternative initial primary therapy for PACG and how to set a target intraocular pressure for PACG. 3) Myopia. Dr Liang has established a rural and an urban cohort of school-aged children for myopia study to investigate environmental effects on myopia and the linkage of near-work induced transient myopia with permanent myopia. Several strategies of reducing the NITM, including vision therapy and Chinese traditional medicine will be tested for the prevention of myopia.
Jeffrey LIEBMANN, USA|
Dr. Liebmann graduated from Boston University's Combined Six-Year Medical Education Program in 1983, completed his ophthalmology residency at the State University of New York/Downstate Medical Center, and glaucoma fellowship training at the New York Eye and Ear Infirmary. Dr. Liebmann was previously Clinical Professor of Ophthalmology at New York University School of Medicine and Director of Glaucoma Services at Manhattan Eye, Ear, and Throat Hospital and New York University Langone Medical Center. Dr. Liebmann currently serves as President of the World Glaucoma Association, past-President of the American Glaucoma Society, Secretary-Treasurer of the New York Glaucoma Society, and co-editor of Journal of Glaucoma and is a member of the Board of Governors of the World Glaucoma Association and Boards of Directors of The Glaucoma Foundation and the American Glaucoma Society Foundation.
Dr. Liebmann is also the Principal Investigator of the African Descent and Glaucoma Evaluation Study and is the author and/or co-author of more than 1,000 medical and scientific papers, book chapters, and abstracts. He has lectured widely in the United States and abroad on glaucoma diagnosis and management. His current main areas of research interest include the causes of glaucoma, glaucoma progression, glaucoma surgery, ocular imaging, and neuroprotection.
Xiaofeng LIN, China|
Prof Xiaofeng Lin is currently the Deputy Director of Zhongshan Ophthalmic Center, Sun Yat-sen University, China. Prof Lin is a member of the Ocular Trauma Association of the Chinese Ophthalmology Society (COS). He received his bachelor degree of Clinical Medicine, Master's and Doctorate degrees of Ophthalmology from Sun Yet-Sen University of Medical Science.
Prof Lin is a well-recognized specialist in ocular trauma and inflammatory eye diseases. He has been involved in innovated surgical skills for the treatment of endophthalmitis and his research mainly focuses on endophthalmitis, pathogenesis, and assessment of potential risk factors, new diagnostic methods and the development of the foldable capsular vitreous body in severe ocular trauma.
Shirley LIU, China
Shirley Liu, PhD, received her doctorate degree 5 years after completing her undergraduate medical training and was a Research Assistant Professor at the Department of Ophthalmology & Visual Sciences of the Chinese University of Hong Kong, Hong Kong. As a clinician-scientist, Dr. Liu’s research interests are focused on the investigation and management of glaucoma, imaging of the retina, optic disc and anterior chamber angle. She is a reviewer of three international journals, including JAMA Ophthalmology, Investigative Ophthalmology and Visual Science, and PLoS One. She has more than 30 publications and has co-authored one book. Dr. Liu has received a number of local and international research awards including the International Travel Grant Award (2011) from The Association for Research in Vision and Ophthalmology (ARVO), and the Hong Kong Vision Foundation Travel Grant Award (2010). She was a Runner-Up in the American Society of Cataract and Refractive Surgery (ASCRS) Film Festival in 2008 and won the Best Presentation in the 2nd National Doctoral Forum in China in 2011.
Yizhi LIU, China|
Prof. Yizhi Liu, MD, PhD, is a professor of ophthalmology and visual science and director of Zhongshan Ophthalmic Center at Sun Yat-sen University. He is currently serving as a standing committee member of the Asia-Pacific Academy of Ophthalmology (APAO), vice president of the Chinese Ophthalmological Society (COS), deputy director of the Cataract and Intraocular Lenses Division of COS and a committee member of the Guangdong Ophthalmological Society. Dr. Liu is also serving as coeditor-in-chief of Molecular Vision and associate editor of Current Molecular Medicine.
As a clinical ophthalmologist, he is recognized as one of the pioneer ophthalmologists in China who perform phacoemulsification and intraocular lens implantation. He has so far carried out approximately 200,000 surgical operations for cataract patients.
Dr. Liu's research focuses on the molecular architecture controlling ocular stem cells' self-renewal and differentiation, along with the genomic and epigenetic mechanisms of cataract and many other age-related eye diseases. He has published over 100 research articles and case reports in leading scientific journals such as Nature, Science, New England Journal of Medicine and PNAS. Dr. Liu is the recipient of numerous awards, including the APAO Arthur Lim Award.
Edward MANCHE, USA|
Edward E. Manche, MD, is a professor of ophthalmology and director of the Cornea and Refractive Surgery Service at the Byers Eye Institute at Stanford University School of Medicine. He received his medical degree from Albert Einstein College of Medicine and completed residency training at the University of Medicine and Dentistry in New Jersey where he served as chief resident. He completed a two-year fellowship in cornea and refractive surgery at the Jules Stein Eye Institute at UCLA.
Dr. Manche is a fellow of the American Academy of Ophthalmology and received its Achievement Award in 2003 and its Senior Achievement Award in 2014. He was elected to active membership in the American Ophthalmological Society in 2011 and is recognized in Best Doctors in America and Guide to America's Top Physicians. He serves on the editorial boards of the American Journal of Ophthalmology, Journal of Ophthalmology, Clinical and Experimental Ophthalmology and Journal of Refractive Surgery. He lectures widely on topics in cornea and refractive surgery and has published over 100 peer-reviewed articles and 25 book chapters.
Frank MARTIN, Australia|
Frank J Martin is President of APAO and APSPOS. He is a Clinical Professor in Ophthalmology and Paediatrics and Child Health at the University of Sydney and holds an attachment to Sydney Children’s Hospitals Network and to Sydney Eye Hospital. He is also Chairman of the Board of the Children’s Medical Research Institute and Chairman of the Westmead Hub Council. He is a past President of RANZCO and has been recognised for his contribution to ophthalmology by the award of the College Medal. Frank was made a Member of the Order of Australia in 2001. In 2011 Frank was awarded APAO’s highest award for a clinician in the region, the Jose Rizal Medal, and also received a vocational excellence award from Rotary.
Charles McGHEE, New Zealand|
Professor Charles NJ McGhee, MBChB, BSc(Hons), PhD, FRCS, FRCOphth, FRANZCO, is the Maurice Paykel Foundation Professor and Chair of Ophthalmology, University of Auckland He is also the Director of the New Zealand National Eye Centre which brings together 120 scientists and clinicians from diverse ophthalmology, optometry and laboratory groups to form one of the largest vision research groups in the Asia-Pacific region. He has edited 3 textbooks, and published more than 250 reviewed scientific papers and chapters on aspects of anterior segment disease and corneal surgery with particular interests in corneal transplantation, ocular pharmacology and corneal imaging. He has also published widely on research and publication in ophthalmology and the scientometrics of eye journals and authors. He is recent past Editor in Chief of Clinical and Experimental Ophthalmology, the journal of the Royal Australian and New Zealand College of Ophthalmologists (RANZCO), and is on the editorial board of three other journals. He has enjoyed a long association with the Asia Pacific Academy of Ophthalmology and has been Scientific Chair, or Co-Chair, of three APAO annual conferences.
William MIELER, USA
Dr. Mieler is an expert in treating diseases of the macula, retina and vitreous. His primary research interests are ocular pharmacology, exploring drug delivery to the posterior segment of the eye, uptake and potential toxicity of topical, periocular and systemic medications, intraocular tumors and response to therapy and ocular imaging. He also participates in numerous national clinical trials for the treatment of age-related macular degeneration, diabetic macular edema, venous occlusive diseases and vitreoretinal interface disorders. Dr. Mieler received the Life Achievement Honor Award from the American Board of Ophthalmology (AAO) and served as its director, vice-chair and chair. He is a past president of the Macula Society, which awarded the 2013 J. Donald Gass Medal to him for his outstanding contributions to the study of macular diseases. He has published 330 peer-reviewed articles, 70 book chapters and edited or co-edited six ophthalmic textbooks. He has delivered 19 named lectures, served on editorial boards for three ophthalmic journals and is a reviewer for 22 additional journals. He is Retina Section Trustee and President-Elect of the Association for Research in Vision and Ophthalmology (ARVO). Dr. Mieler also served on several committees of the American Board of Medical Specialties. He joined the Illinois Eye and Ear Infirmary in 2008. Dr. Mieler is board certified in ophthalmology.
Marilyn MILLER, USA
Marilyn T. Miller, MD, Professor of Ophthalmology, Department of Ophthalmology and Visual Sciences University of Illinois at Chicago, Chicago, IL, USA. Dr Marilyn Miller is Professor of Ophthalmology and faculty of the Pediatric Ophthalmology and Strabismus Section of the Department of Ophthalmology and Visual Sciences at the University of Illinois. Dr Miller has a major commitment to international ophthalmology, especially in children’s eye programs around the world in the past. She served on the Advisory Committee of World Health Organization, the Board of the American Academy of Ophthalmology (AAO), the Advisory Board of the AAO, and was the Chair for many years of the AAO Committee on International Ophthalmology, and their representative to the International Agency for the Prevention of Blindness. She has been involved in the Program Committees for pediatric ophthalmology of some of the World Congress of Ophthalmology and the Asian-Pacific Ophthalmology meetings. Her research interests are in the area of teratology, congenital ocular anomalies and unusual strabismus syndromes.
Toshinori MURATA, Japan|
Dr Toshinori Murata, MD, PhD, is Professor and Chairman of the Department of Ophthalmology, Shinshu University, School of Medicine, Matsumoto, Japan. He was a Research Associate under Dr Stephen Ryan at the Doheny Eye Institute, University of Southern California, Los Angeles, California in 1996. He investigated the mechanisms of choroidal neovascularization and its experimental treatment. His research work has been summarized in the Chapter, “Choroidal Neovascularization,” in the fourth edition of RETINA published in 2006 by Elsevier Mosby. In 1998, he received the Postdoctoral Fellowship Award from the Juvenile Diabetes Research Foundation for his research on the causative role of vascular endothelial growth factor (VEGF) in diabetic retinal edema, and continued his research work at Children's Hospital Boston from 1998 to 1999. After he returned to Japan, in addition to his research, he has been performing vitrectomy for diabetic retinopathy and anti-VEGF therapy for choroidal neovascularization in age-related macular degeneration. His previous research work is now directly utilized in the treatment of the patients with diabetic retinopathy and age-related macular degeneration in which neovascularization plays a critical role. He is a Diplomat of Ophthalmology certified by the Japanese Ophthalmological Society (JOS) and is a Supervisor in Clinical Ophthalmology certified also by the JOS. He currently is a member of Annual Meeting Program Committee of Association in Research in Vision and Ophthalmology.
Toru NAKAZAWA, Japan|
Dr Toru Nakazawa is an associate professor in the department of Ophthalmology at the Tohoku University Graduate School of Medicine. His clinical and research work mainly focus on the pathogenesis of glaucoma and retinal diseases leading to blindness. He wishes to develop new insights and therapeutic approaches that combine clinical and basic research, especially in the neuroprotective treatment of glaucoma and retinal diseases.
Ken NISCHAL, UK|
Dr. Ken K Nischal MD , FRCOphth, is Professor of Ophthalmology , University of Pittsburgh and Director of the UPMC Children's Eye Center , Children's Hospital of Pittsburgh and Chief of Pediatric Ophthalmology and Adult Motility.
He was attending and then head of the department of Ophthalmology, Great Ormond St Hospital for Children, London, UK from 1999 until 2011. His fellowship training was at the Hospital for Sick Children, Toronto in 1998.
His focus is on evidence based protocol led clinical care with clinical outcome measures as a source of clinical research. His main areas of clinical research are anterior segment developmental anomalies affecting the cornea, lens and trabecular meshwork. He has published widely in pediatric cataract, glaucoma and cornea and also craniofacial anomalies.
Kohji NISHIDA, Japan
Kohji Nishida is the Professor and Chairman of the Department of Ophthalmology of Osaka University Graduate School of Medicine and his major fields of interests include ophthalmology, corneal transplantation and stem cell biology. Prof Nishida obtained his PhD and MD from Osaka University Medical School. He had started his career as a stuff surgeon in Ophthalmology at Osaka Koseinenkin Hospital and became an assistant professor in Ophthalmology at Kyoto Prefectural University of Medicine in 1992. He used to be a research associate in neural stem cell biology and gene therapy in Professor Fred H. Gage’s Lab of the Genetics Department of the Salk Institute in San Diego, the USA. He then became an assistant professor in Ophthalmology in Osaka University Medical School and was promoted to be associate Professor. Prof Nishida was the Professor and Chairman of the Department of Ophthalmology and Visual Science of Tohoku University Graduate School of Medicine from 2006 – 2010. He then continued his career with Osaka University and became the Professor and Chairman of the Department of Ophthalmology of the Osaka Graduate School of Medicine.
Stephen A. OBSTBAUM, USA
The American Academy of Ophthalmology is pleased to recognize Stephen A. Obstbaum, MD as a 2006 Guest of Honor for his leadership and contributions to ophthalmology. Dr Obstbaum was born in New York City and received his medical degree in 1967 from New York Medical College. Following his residency at Flower and Fifth Avenue Hospitals, New York Medical College, Dr Obstbaum completed a National Eye Institute Special Fellowship in glaucoma at Washington University in St. Louis in 1973. Dr Obstbaum is Professor of Ophthalmology at New York University Medical School and Chairman of the Department of Ophthalmology at Lenox Hill Hospital Department of Ophthalmology in New York. He is also a Professorial Lecturer at Mount Sinai School of Medicine in New York. Dr Obstbaum is also a widely published author, having authored or co-authored more than 100 articles, books, book chapters and abstracts on lens and glaucoma relationships, ocular inflammation related to cataract surgery and refractive surgery. Dr Obstbaum was the 101th president of the American Academy of Ophthalmology in 1997. He has served the Academy for almost 2 decades including, chair of the Ad Hoc Committee on Eye Care, chair of the Young Ophthalmologists Committee, chair of the Cataract Surgery Preferred Practice Patterns, a member of the Ad Hoc Committee for Organizational Redesign, member and then chair of the Long Range Planning Committee, member of the Advisory Board of the Academy’s Foundation, former academy Councilor, and Senior Secretary for Advocacy and Public Affairs. He has been awarded the St. Erik’s Medal by the Karolinska Institute, Stockholm, and the New York Medical College Alumni Academic Achievement Award. Major medical committee appointments include the National Study of Outcomes of Cataract Surgery Patients Outcomes Research Team (PORT) Study, Johns Hopkins School of Hygiene and Public Health; the Guideline for Management of Functional Impairment Due to Cataract, the Agency for Health Care Policy and Research; and the Technical Consultant group for the Harvard/RBRVS. Active in many professional organizations, Dr Obstbaum is currently Secretary (English Language) of the Pan American Association of Ophthalmology, has served as President of the International Intraocular Implant Club and President of the American Society of Cataract and Refractive Surgery. He has been appointed to numerous editorial boards, including the European Journal of Cataract and Refractive Surgery, the German Journal of Ophthalmology, Ophthalmic Surgery, Pan-Asia Journal of Ophthalmology, the Archives of Ophthalmology and Argus, as well as serving as editor of the Journal of Cataract and Refractive Surgery for 20 years, and is currently Chief Medical Editor of EyeWorld. Dr Obstbaum lives in Leonia, New Jersey, with his wife. It is with great appreciation and pleasure that the Academy recognizes Dr Stephen Obstbaum as a 2006 Guest of Honor.
Ki Ho PARK, Korea|
Ki Ho Park is a professor of ophthalmology at Seoul National University. He is involved with many eye journals: section editor of the British Journal of Ophthalmology and Japanese Journal of Ophthalmology; editorial board member of the Asian Journal of Ophthalmology, Korean Journal of Ophthalmology, Taiwan Journal of Ophthalmology, etc. He is on the Board of Governors of the World Glaucoma Association, is a board member of the Asia-Pacific Glaucoma Society and serves as secretary general of the Asian Angle Closure Glaucoma Club (AACGC). He is serving as Scientific Program Chair of the 2016 Asia-Pacific Glaucoma Congress.
Previously, he was secretary general and co-chair of the South East Asian Glaucoma Interest Group Meeting and AACGC Meeting (2008, Seoul, Korea) Organizing Committee.
He was awarded the American Academy of Ophthalmology Achievement Award (2012), Asia-Pacific Academy of Ophthalmology (APAO) Achievement Award (2012), APAO Distinguished Service Award (2005) and Jules Stein Eye Institute Laboratory Research Award (2000).
Prof. Park has published more than 150 papers in international peer-reviewed SCI journals. He was editor of Atlas of Angle Closure Glaucoma (2010) and associate editor of Angle Closure Glaucoma (2007). His research interests include risk factors of glaucoma, retinal nerve fiber layer and ganglion cell imaging, normal-tension glaucoma, angle-closure glaucoma and neuroprotection. Lastly, he is the current president of the Korean Glaucoma Society.
Dipika PATEL, New Zealand
Dr Dipika Patel began her pre clinical medical training at Cambridge University, obtaining a first class honours degree in Physiology, and went on to complete her clinical training at Oxford University. She became a member of the Royal College of Ophthalmologists (UK) in 2001. Dipika joined the Department of Ophthalmology, University of Auckland, in 2003 for a three year clinical/research fellowship in cornea and anterior segment. During this time she successfully completed her PhD thesis, entitled ‘in vivo confocal microscopy of the cornea in health and disease’ and won the University of Auckland best doctoral thesis award. She is currently Associate Professor in Ophthalmology at the University of Auckland where she continues to pursue her research interests which include anterior segment imaging and investigating potential therapeutic applications for corneal stem cells.
Calvin Chi Pui PANG, Hong Kong
Professor Calvin Chi Pui PANG, BSc (Lond), DDPhil (Oxon). S. H. Ho Professor of Visual Sciences, Professor of Ophthalmology & Visual Sciences, Head, Graduate Division of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong Eastern Scholar and Chair Professor, Shanghai Municipal Education Committee Deputy Director, Shantou University / Chinese University of Hong Kong Joint Shantou International Eye Center Laboratory Director, Shenyang Eye Research Institute. Honorary or visiting professor of 12 universities or research institutions. Reviewer for more than 20 international journals, including IOVS and Ophthalmology. Reviewer for 10 national and international research grant bodies, including Wellcome Trust UK, National Science Foundation China, and National Medical Research Council, Singapore. Major research: (1) Genomic studies and gene mapping on glaucoma, age-related macular degeneration, high myopia, and congenital cataracts. (3) Molecular genetics, mechanisms, and epi-genetics of retinoblastoma, Bietti crystalline dystrophy, Graves’ ophthalmopathy, retinitis pigmentosa, uveitis, and cornea dystrophies. (4) Biology of ocular stem cells. (5) Biological effects of herbal chemicals. 270 papers in international peer reviewed SCI journals and 11 book chapters.
Uwe PLEYER, Germany|
Dr. Uwe Pleyer, FEBO, is currently a professor of ophthalmology at the Charité, Humboldt University in Berlin, Germany. Previously, he worked as an assistant professor at University Eye Hospital, Tübingen, Germany. He completed his medical and doctoral education at Rheinisch-Westfählische Technische Hochschule in Aachen, Germany; Cornell University, New York; and University Eye Hospital in Tübingen. Dr. Pleyer worked as a resident at Eberhard-Karls-University, Tübingen, Germany and as a postdoctoral fellow at the Jules Stein Eye Institute, UCLA, where he specialized in immune-mediated eye diseases. He concluded further clinical and research fellowships at ophthalmology centers in India and the US.
Dr. Pleyer has served as principal investigator for both national and international trials in ophthalmology. He is a member of several scientific societies including the European Society of Cataract and Refractive Surgeons (ESCRS), the European Association for Vision and Eye Research (EVER), the Deutsche Ophthalmologische Gesellschaft, the Association for Research in Vision and Ophthalmology and the American Academy of Ophthalmology. He was president of EVER (2007), is a task force member for ESCRS and a founding member of the International Ocular Inflammation Society.
He is involved in both research and clinical treatment of infectious and immune-mediated ocular diseases. Dr. Pleyer has published over 300 peer reviewed articles, is (co-)editor of 14 books and editor-in-chief of Ophthalmic Research (2002-2014). In addition, he is on the editorial boards of a number of journals such as Acta Ophthalmologica, Asia-Pacific Journal of Ophthalmology, European Ophthalmic Review, Journal of Ophthalmic Inflammation and Infection, Ophthalmic Research, Ocular Immunology and Inflammation and Ophthalmologica. Dr. Pleyer has received several honors and awards including the esteemed International Chibret Award, B. Straatsma Award (UCLA) and Max Rubner Preis (2015.
Francis PRICE, USA|
Dr. Price graduated Phi Beta Kappa from the University of Notre Dame. He earned his medical degree from Indiana University Medical School, where he also completed his residency in ophthalmology. He completed a prestigious fellowship in corneal and external eye disease at Tulane University.
Dr. Price has earned national and international recognition for his research and contributions in the field of ophthalmology. In the past 10 years, more than 700 corneal surgeons from more than 30 countries have attended Dr. Price's surgical training classes in Indianapolis. In addition, Dr. Price is regularly requested to present talks at eye meetings around the world. He has been a principal investigator in more than 100 clinical research studies and has conducted his own studies on ophthalmic medications and devices, such as Excimer lasers, as well as surgical procedures including LASIK and cornea transplants. He played a key role in the research that led to the approval of LASIK in the United States. He is also a teacher, lecturer and inventor, holding U.S. patents for special devices used in ophthalmic surgery.
Dr. Price has published more than 160 ophthalmic articles in peer-reviewed journals and authored several cornea textbooks. His articles are among the most highly cited in the field of ophthalmology, as evidenced by his high "impact factor" which tracks the number of times that articles are cited.
Jose PULIDO, USA
Dr Jose Pulido is a professor in the Department of Ophthalmology at the Mayo Clinic College of Medicine in Rochester, Minnesota. He has served as the head of the Department of Ophthalmology and Visual Sciences at the University of Illinois. He completed his residency at the University of Illinois and was honored as the Chief Resident. He had two fellowships, the first at Bascom Palmer Eye Institute in Florida as well as an ocular oncology fellowship at the Wills Eye Hospital in Philadelphia, PA. Dr Pulido is currently involved in a research grant on vaccine treatment of melanomas by causing autoimmunity. He was a part of the original retinal prosthesis work and developed the ganciclovir and rituximab ocular toxicity studies. He has published more than 225 scientific papers and chapters as well as three books.
Narsing RAO, USA |
Dr Rao is Professor of Ophthalmology and first chair holder of Stieger Vision Research Endowed chair at the University of Southern California. He was awarded medical degree from Osmania University, Hyderabad and completed residencies in pathology and ophthalmology at the Georgetown University, and a fellowship at the Armed Forces Institute of Pathology, Washington, D.C. His research endowers focus on uveitis and related ophthalmic inflammatory diseases and such work is supported by grants from National Institute of health continuously since 1985 He has published over 400 peer reviewed articles on ophthalmic diseases in the United States, three books and the American Registry of Pathology-AFIP fascicle on Tumors of the Eye and Ocular Adnexa. He is recipient of several awards including Lorenz Zimmerman, Bietti and International Uveitis medals.
Ravi RAVINDRAN, India|
Dr. Ravi Ravindran started his ophthalmology practice in 1987 under the guidance of Dr. G. Venkataswamy, founder of the Aravind Eye Care System. From this beginning, Dr. Ravindran was later involved in starting Aravind Eye Hospitals in Tirunelveli, Coimbatore and Pondicherry, fulfilling the mission of the Aravind Eye Care System to serve the eye care needs of millions globally. During this period he was also involved in starting and popularizing manual small incision cataract surgery in Aravind hospitals and around the region.
After serving as Chief Medical Officer at the Aravind Eye Hospitals in Tirunelveli, Coimbatore and Pondicherry for around 20 years, Dr. Ravindran became chairman of the Aravind Eye Care System in July 2010. He was involved in making changes to standardize "quality eye care" across the Aravind Eye Care System. Apart from managing and mentoring key leaders of the institution, his fields of interest include patient safety and quality assurance. He is involved in teaching eye health management courses leading to capacity building at other eye hospitals. He has presented papers at numerous international and national conferences on both the clinical and managerial aspects of eye care.
He has been an active member of the ophthalmological society of Tamil Nadu state and also the All India Ophthalmological Society for the past 25 years. He served as a regional co-chair for the International Agency for the Prevention of Blindness from 2004 to 2012 and also as president of city ophthalmological associations. Currently he is a board member of VISION 2020 Right to Sight India (since 2008), chairman of the International Relations Committee of the All India Ophthalmological Society and also serves on the panel for standardizing treatment guidelines for ophthalmology in India. He is a recipient of several national and international awards.
Robert RITCH, USA
Dr Robert Ritch holds the Shelley and Steven Einhorn Distinguished Chair in Ophthalmology and is Surgeon Director and Chief of Glaucoma Services at the New York Eye & Ear Infirmary, New York City and Professor of Ophthalmology at The New York Medical College, Valhalla, New York.
He has devoted his career to broadening our understanding of the nature of glaucoma and innovation in the medical, laser, and surgical treatment of glaucoma. Dr Ritch received his B.A. cum laude from Harvard College and an M.A. in cell biology from Harvard University. He received his M.D. from Albert Einstein School of Medicine and, after an internship at St. Vincent’s Medical Center and a residency in Ophthalmology at Mount Sinai School ofMedicine; he received fellowships in glaucoma from the Heed Foundation and the National Institutes of Health.
A Diplomate of the American Board of Ophthalmology, he is a Fellow of the American Academy of Ophthalmology, the American College of Surgeons, the International College of Surgeons, the Royal College of Ophthalmology, the Association for Research in Vision and Ophthalmology, and the New York Academy of Medicine, and is a member of more than 35 scientific and medical societies. Dr Ritch has been President of the Ophthalmic Laser Surgical Society, the New York Glaucoma Society, the Section on Ophthalmology of the New York Academy of Medicine, and the New York Society for Clinical Ophthalmology.
He serves on numerous medical and scientific advisory and editorial boards and is a member of the Glaucoma Research Society, the Steering Committee of the World Glaucoma Association, the Advisory Board of Helen Keller International, and the Board of Governors of the International Society for Imaging in the Eye.
In 1996, Dr Ritch received the Heed Ophthalmic Foundation Ophthalmologist of the Year award and in 1998, the Gold Medal of Merit and Honor from the Greek Glaucoma Society and the Ophthalmology Times Achievement in Ophthalmology Award.
In 1999, he was one of the winners of the Louis Rudin Award for research in ophthalmology.
In 2000, he received the Jesse H. Neal Award for Editorial Achievement.
In 2002, Dr Ritch was appointed to the Advisory Committee to the Board of Directors of the International Council of Ophthalmology and was elected Chairman of the Committee in 2009 and appointed to the Board of Directors of the International Council.
He was elected to the Board of Trustees of the Association for Research in Vision and Ophthalmology and served as Vice-President in 2006-2007.
His awards since 2006 include the Albion O. Bernstein, MD Award of the Medical Society of the State of New York for outstanding contributions to medicine, the American Academy of Ophthalmology Lifetime Achievement Honor Award, the Leadership in Educuation in Ophthalmology (LEO) Award, the Dean’s Distinguished Research Award from the New York Medical College, The Glaucoma Foundation Award for Innovation and Excellence in Glaucoma, the TKC Liu Memorial Award for Leadership in Ophthalmology, the Dominick Purpura Distinguished Alumnus Annual Award from Albert Einstein College of Medicine, the ARVO Distinguished Service Award, ARVO Gold Fellowship, the HRH Prince Abdulaziz Al-Saud Prevention of Blindness Award (2010) and the Jose Rizal International Medal (2011). Dr Ritch has co-authored or edited nine textbooks and over 1500 medical and scientific papers, book chapters, articles and abstracts. He has presented nearly 700 lectures worldwide, including 31 named lectures. In 1985, he founded the Glaucoma Foundation and has served as Secretary, Medical Director, and Chairman of the Scientific Advisory Board.
In 1994, he initiated the annual Optic Nerve Rescue and Regeneration Think Tank, which has attracted numerous successful researchers from other fields into glaucoma research. He also co-founded the New York Glaucoma Research Institute, a not-for-profit foundation to sponsor clinical research in glaucoma, the alt.support.glaucoma Internet newsgroup, the New York Glaucoma Support and Education Group, and the Association of International Glaucoma Patient Organizations.
He was one of the three organizers of the first annual World Glaucoma Day in 2008.
He was co-founder of the Ophthalmic Laser Surgical Society, the New York Glaucoma Society, and the Lindberg Society, an international organization dedicated to the eradication of exfoliation syndrome; the ARVO Host-a-Research Program, the ARVO U.S.-Russia Ophthalmology Task Force, the Von Graefe Society, an international organization dedicated to the study of risk factors for glaucoma other than intraocular pressure.
Dr Ritch has trained over 130 clinical and research fellows, many of whom occupy academic positions worldwide. The international training program that he established at the New York Eye and Ear Infirmary has hosted 30 International Council of Ophthalmology fellows and over 80 observers from over 40 countries.
He has worked and lectured extensively at the international level and has organized many symposia and conferences both in the United States and abroad. He has dedicated most of his time abroad in Asia over the last 30 years, and has organized conferences and symposia, trained over 60 fellows and observers, helped to establish residency and teaching programs and has made fundamental contributions to the modernization of ophthalmology in Thailand, Malaysia, the Philippines, Laos, Myanmar and other countries in Asia.
Tim ROBERTS, Australia
Dr Tim Roberts, MBBS (NSW), M.Med (Syd), FRANZCO, FRACS, is in private practice in Sydney with a special interest in glaucoma, femtosecond laser cataract surgery and refractive IOLs. Dr Roberts graduated in Medicine from the University of New South Wales in 1985. He completed specialist training in Ophthalmology at Sydney Eye Hospital then undertook further advanced study in glaucoma in the United Kingdom and US. He was awarded a Masters of Medicine in 2008 from the University of Sydney for his research into nocturnal cardiovascular and respiratory risk factors in glaucoma. Dr Roberts is a Consultant Ophthalmic Surgeon at Royal North Shore Hospital, where he heads the Glaucoma Unit and is the Director of Training. He is a Clinical Senior Lecturer at the University of Sydney, and holds senior positions in the Royal Australian and New Zealand College of Ophthalmologists as Chairman of the NSW Qualification and Education Committee and as a member of the Federal QEC, College Board of Examiners and NSW State Committee. He also serves as a Scientific Assessor for the Northern Sydney Area Health Service Medical Research Ethics Committee. Dr Roberts has lectured widely on cataract surgery and glaucoma in Australia, South East Asia, UK and the USA and performed live cataract surgery at several international meetings. He has an interest in medical ethics and education and has been involved in field trips to teach ophthalmology throughout outback Australia and South East Asia, most recently with the Myanmar Eye Care programme. He is a member of the cataract surgery programme committee for the Asia Pacific Academy of Ophthalmology.
Paisan RUAMVIBOONSUK, Thailand|
Dr. Paisan Ruamviboonsuk received his certificate of vitreous and retina diseases from Albert Einstein College of Medicine, New York, in 1995. He currently holds the positions of chairman of the Department of Medical Policy Development and Strategic Planning and assistant hospital director at the Center of Medical Excellence, Rajavithi Hospital, Bangkok, Thailand. He is also a retinal specialist serving at the Center of Excellence for Vitreous and Retina Diseases in the same hospital.
Since 2012, Dr. Ruamviboonsuk has been the president of the Royal College of Ophthalmologists of Thailand and was president of the Thai Retina Society from 2009-2014. He is also a regional secretary of the Asia-Pacific Academy of Ophthalmology (APAO), a council member of the Asia-Pacific Vitreo-retina Society and the secretary general of ASEAN Ophthalmology Society.
Dr. Ruamviboonsuk received a United Nations Public Service Award for his project on the prevention of blindness from diabetic retinopathy in 2012. He also received an APAO Distinguished Service Award in 2007 and APAO Achievement Award in 2014. He currently serves as an active reviewer of 5 international peer-reviewed journals and has been an invited speaker at more than 30 international ophthalmology meetings.
Nasir SAEED, Pakistan
Prof. Nasir Saeed graduated from Khyber Medical College, Pakistan in 1981 and Fellowship College of Physicians and Surgeons Pakistan in 1990. He is currently serving as a Professor and Head of the Department of Ophthalmology of the Pakistan Institute of Community Ophthalmology. He is also President-Elect of the Pakistan Glaucoma Association and Provincial Coordinator for the National Program for Prevention and Control of Blindness in Pakistan.
He is an active and senior life member of the Ophthalmology Society of Pakistan (OSP) and has served both as General Secretary and President of the OSP for six years. He is Executive Vice President of the Association of University Teachers of Pakistan and a member of the Faculty of Ophthalmology of the College of Physicians and Surgeons in Pakistan. He is also a coordinator of the International Council of Ophthalmology.
Prof. Saeed is a dedicated and devoted teacher, teaching both undergraduates and postgraduates over the past 25 years. He has trained more than 50 fellows. He is also a keen researcher and has published 35 papers in various national and international journals. He is a co-author of Glaucoma National Guidelines and is on the Editorial Board of a number of journals. His basic research interests are ophthalmic education, glaucoma and community ophthalmology.
Prof. Saeed received the Meritorious Services Award in field of Ophthalmology in Pakistan in 2007, the Ramazan Ali Syed Gold medal Award in 2010 and the Distinguished Services Award from the Asia-Pacific Academy of Ophthalmology in 2010. He is a graduate of the Leadership Development Program organized by the American Academy of Ophthalmology and is also a graduate of the Leadership Development Program organized by the Asia-Pacific Academy of Ophthalmology. Prof. Saeed is a leader in eye health recognized by the International Agency for Prevention of Blindness.
Seang SAW, Singapore|
Prof. Seang Mei Saw is head of the Myopia Unit at Singapore Eye Research Institute and professor at Saw Swee Hock School of Public Health, National University of Singapore. She has an MBBS degree from the National University of Singapore and a PhD in epidemiology from the Johns Hopkins Bloomberg School of Public Health.
Her research interests are the epidemiology and genetics of eye diseases. She is the principal investigator of several large epidemiologic studies including Singapore Cohort Study of the Research Factors for Myopia (SCORM); Strabismus, Amblyopia and Refractive Error Study in Singapore Preschool Children (STARS); and the birth cohort, Growing Up in Singapore Towards Healthy Outcomes (GUSTO). The highlights of her research include elucidating the genes and environmental factors for myopia and pathologic myopia.
Prof. Saw has published more than 400 peer-reviewed manuscripts in international journals, including the Lancet, Journal of the American Medical Association and Nature Genetics. She is associate editor of Translational Vision Science and Technology and an editorial board member of Investigative Ophthalmology and Visual Science, Ophthalmic and Physiologic Optics, Asia-Pacific Journal of Ophthalmology and Case Reports in Ophthalmology.
She is a recipient of several awards including the ARVO Gold Fellow (2015); Asia-Pacific Academy of Ophthalmology Achievement Award (2015); Mochtar Riady NUHS Excellence Award (2015); Bernard Gilmartin OPO Award (2014); Sek-Jin Chew Memorial Lecture Award (2013); ARVO Silver Fellow (2012); Garland W. Clay Award (2006); the Great Women of our Times Award, Science and Technology Category, Singapore (2006); the American Academy of Ophthalmology Achievement Award (2009); and the NUS School of Medicine Faculty Research Excellence Award (2009). Prof. Saw was chair of the 11th International Myopia Conference held in Singapore in 2006 and chair of the 2010 Program Committee, clinical/epidemiologic section, for the Association for Research in Vision and Ophthalmology.
Leopold SCHMETTERER, Austria|
Leopold Schmetterer, PhD, FARVO, is currently the chair of the Ophthalmic Pharmacology Division in the Department of Clinical Pharmacology and a principal investigator at the Center of Medical Physics and Biomedical Engineering at the Medical University of Vienna.
His research interests include a wide array of subspecialties in ophthalmology, including imaging, glaucoma, medical retina and dry eye syndrome. Dr. Schmetterer was recently responsible for the MANTA study, a multicenter study in Austria that compared the effects of ranibizumab and bevacizumab for the treatment of neovascular age-related macular degeneration.
He graduated from the Technical University of Vienna in 1989. Between 1996 and 1998, Dr. Schmetterer held a postdoctoral position at the Institute de Recherche en Ophthalmologie in Sion working with Dr. Charles Riva. He was a guest professor at EPFL in Lausanne between 1998 and 2002.
Dr. Schmetterer has experience in organizing scientific conferences for several associations. He served on the PH Section of the Annual Meeting Program Committee for ARVO between 2009 and 2011 and became an ARVO Silver Fellow at the 2014 annual meeting in Orlando. In 2012, he was president of European Vision and Eye Research (EVER), the largest European ophthalmological research conference. He was elected president of the EVER Foundation in 2013 for a four-year period. He is also involved in the International Symposium on Ocular Pharmacology and Therapeutics (program committee member since 2009) and the World Ophthalmology Congress (program committee member for the 2014 meeting in Tokyo). He is also on the Scientific Committee of the Austrian Ophthalmological Society, president of the Association of Ocular Circulation, representative of medicine in the council of the Austrian Science Fund and a founding member of the European Alliance for Vision Research and Ophthalmology. He was a member of the European Medical Research Council from 2010 to 2012.
Dr. Schmetterer is a member of many editorial boards, including Progress of Retinal and Eye Research, Acta Ophthalmologica, Current Eye Research, Journal of Ocular Pharmacology and Therapeutics and Ophthalmic Research. He has published more than 250 articles in peer-reviewed journals and more than 50 book chapters. He recently edited a book on ocular blood flow. Dr. Schmetterer has received continuous funding from national and international sources for more than 15 years for a total of €5 million. He was recently appointed director of Christian Doppler Laboratory for Ocular Effects of Thiomers, a joint program between industrial and academic institutions.
Shwu-Jiuan SHEU, Chinese Taipei|
Prof. Shwu-Jiuan Sheu is currently chief of ophthalmology at Kaohsiung Veterans Hospital in Taiwan and professor at National Yang-Ming University and National Defense Medical University in Taipei.
Prof. Sheu graduated from Kaohsiung Medical University in 1984. She completed her residency and proceeded to attain fellowships in ophthalmology at Taipei Veterans General Hospital, Taiwan, in 1989 and the Doheny Eye Institute, University of Southern California, USA, in 1992.Her membership in ophthalmological societies and editorial boards includes the following: Taiwan Ophthalmological Society, American Retinal Society, Taiwan Retinal Society, Association for Research in Vision and Ophthalmology, International Ocular Inflammation Society, Taiwan Journal of Ophthalmology and Journal of Ocular Inflammation and Immunology.
Her research interests include vitreoretinal disease diagnosis and treatment, uveitis and retinal cell biology. She is known for her dedication to scientific research and has publications on vitreoretinal disease, cataract surgery, diabetic retinopathy, age-related macular degeneration, retinal detachment, uveitis and related laboratory topics..
Jerry A. SHIELDS, USA
Jerry A. Shields MD is director of Oncology Service, Wills Eye Institute and Professor of Ophthalmology, Thomas Jefferson University, Philadelphia. He was a resident at Wills Eye Hospital and completed fellowships in ophthalmic pathology and retinal surgery. For more than 35 years, he has been active in care of patients with ocular tumors and in clinical research related to tumors of the eyelids, conjunctiva, intraocular structures, and orbit. He has authored or co-authored 1154 articles in scientific journals and 501 textbook chapters for a total of 1655 scientific publications. He has authored or co-authored 13 major textbooks and has given 1453 national and international lectures, including 63 named lectures. He has received 28 national and international academic awards for his contributions. Dr Shields has served on editorial boards of 14 journals. He was the organizer and first president of the International Society of Ocular Oncology, president of the Ophthalmic Club of Philadelphia, president of Wills Eye Medical Staff, and president of the Macula Society. Dr Shields is married to Dr Carol Shields who also practices on the Oncology Service of Wills Eye Institute and has made many contributions in ocular oncology. They have 7 children ranging from 22 to 11 years of age.
Rita SITORUS, Indonesia |
Dr Rita S Sitorus, currently a senior member, Professor and senior researcher at Paediatric Ophthalmology of Faculty of Medicine University of Indonesia, Dr Cipto Mangunkusumo Hospital, Jakarta-Indonesia, is a pediatric ophthalmologist with special interest in childhood blindness, retinoblastoma, and genetic eye diseases. She spent about 5 years of her time in Germany, Japan, and the Netherlands, taking fellowships in pediatric ophthalmology, as well as performing research on clinical and molecular eye diseases, until her completing PhD degree at Vrije University medical center, Amsterdam. Her passion in contributing to the prevention of childhood blindness and retinoblastoma in Indonesia had encouraged her to publish remarkable articles on her field of interests, in addition to her participation in ”the International Retinoblastoma Staging Working Group” and her establishment of ROP related blindness prevention program and strategy in Indonesia. Her recent work in writing includes external reviewer of International Scientific Journals, external reviewer for Cochrane Acute Respiratory Infections Group by University of Queensland, and the associate editor of the national Journal Ophthalmologica Indonesiana.
Justine R. SMITH, USA
Justine R. Smith, MBBS, PhD, is currently Associate Professor of Ophthalmology and the Thelma & Gilbert Schnitzer Professor of Ophthalmic Research at the Casey Eye Institute, Oregon Health & Science University. Dr Smith practices in the ophthalmic subspecialty of uveitis, and she has participated in multiple international clinical workshops aimed at improving the management of patients with this disease, including the Standardization of Uveitis Nomenclature Working Group. In addition to her clinical work, Dr Smith heads a National Institutes of Health-funded translational research group that studies the role of the retinal vascular endothelial cell in ocular inflammation. Dr Smith is the current Immunology & Microbiology Trustee on the Association for Research in Vision and Ophthalmology (ARVO) Board, and a member of the Council of the American Academy of Ophthalmology (AAO). She also sits on the Executive Committee of the American Uveitis Society and the International Council of the International Ocular Inflammation Society. Dr Smith is author of 100 peer-reviewed publications, and she is a 6-time recipient of the European Uveitis Patient Interest Association annual prize for the best papers in clinical or experimental uveitis.
Tarun SHARMA, India|
Dr. Tarun Sharma completed his medical graduate degree from Government Medical College, Patiala, Punjabi University, Punjab, India, in 1981. He obtained an MD (ophthalmology) from Government Medical College, Punjabi University, Punjab, India, in 1985 and FRCS in September 2001 at Sankara Nethralaya, Chennai. His fellowship training in vitreoretinal surgery took place at Sankara Nethralaya, Chennai between 1985 and 1986.
Dr. Sharma joined Sankara Nethralaya in 1986 as a registrar. He served as a consultant between 1986 and 1991 and as a senior consultant between 1991 and 2001. Since 2001, he has been the director of Shri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai.
He has published 76 papers in peer-reviewed national and international journals and has also written eight chapters in various ophthalmic books. He has participated in 38 national and international conferences as an invited guest speaker.
As a visiting scholar, he visited the Chinese University of Hong Kong, Hong Kong, in 1997 and 1998. He is a member of the editorial board of the Hong Kong Journal of Ophthalmology. He is a reviewer for the Hong Kong Journal of Ophthalmology, Indian Journal of Ophthalmology, Ophthalmology and Hong Kong Medical Journal.
He holds membership in the Tamil Nadu Ophthalmic Association, All India Ophthalmological Society, Vitreoretinal Society of India and American Society of Retinal Specialists.
Bhaskar SRINIVASAN, India|
Dr. Bhaskar Srinivasan is currently on deputation working at the C-MER (Shenzhen) Dennis Lam Eye Hospital as a cornea specialist. He received his MBBS in 1997 from Mumbai University and then completed his master's in ophthalmology from the Armed Forces Medical College in Pune, India. He was the top university student in the MS exams. He then joined the world-renowned ophthalmic hospital Sankara Nethralaya for a cornea and anterior segment fellowship, completed in 2004. After that, he joined the organization as a faculty member. He has been associated with Sankara Nethralaya since then and at present, his designation is senior consultant in cornea and refractive services.
He is an integral part of a team specifically dedicated to treating ocular surface diseases. It is one of the very few centers in the world that offer various stem cell treatment options and keratoprosthesis under one roof. Along with his colleagues, he has done more than 150 keratoprosthesis surgeries (modified osteo-odonto keratoprosthesis, Boston type 1 and 2 and osteo-keratoprosthesis). He has 29 publications in peer-reviewed literature and has been a part of numerous national and international meetings. He was the co-organizing secretary of OSKON, an exclusive ocular surface and keratoprosthesis conference, conducted in 2012 and 2015 in Chennai, India.
Tim SULLIVAN, Australia|
Prof. Tim Sullivan completed his ophthalmology training in Queensland in 1988. He then undertook fellowship training in oculoplastics (1990) and orbital and lacrimal disease (1992) at Moorfields Eye Hospital and pediatric ophthalmology at the Hospital for Sick Children in Toronto (1991).
Prof. Sullivan specializes in adult and pediatric eyelid, lacrimal and orbital disease.
He now conducts the Eyelid, Lacrimal and Orbital Clinic at the Royal Brisbane and Women's Hospital and Royal Children's Hospital. Prof. Sullivan has over 100 publications in peer-reviewed journals, several book chapters and over 270 presentations at national and international meetings.
He is a former president of the ANZ Society of Ophthalmic Plastic Surgery and the Asia-Pacific Society of Ophthalmic Plastic and Reconstructive Surgery. He has been an invited speaker for the American Academy of Ophthalmology and Canadian Ophthalmology Society, a keynote speaker for the European and British Oculoplastic Societies and a featured invited speaker at the American Society of Ophthalmic Plastic and Reconstructive Surgery.
Donald T.H. TAN, Singapore
Professor Donald Tan is the Medical Director of the Singapore National Eye Centre (SNEC), Chairman of the Singapore Eye Research Institute (SERI) and Professor of Ophthalmology at the National University of Singapore. He heads the SNEC Cornea and Refractive Services and is also Medical Director of the Singapore Eye Bank. A corneal and refractive surgeon by training, his research contributions lie in new forms of selective lamellar keratoplasty, femtosecond corneal and refractive surgery, the Osteo-Odonto Keratoprosthesis (OOKP) artificial cornea, surgical devices for lamellar corneal transplantation, and interventional myopia clinical trials. He has published over 250 peer-reviewed articles, contributed 18 book chapters and holds 12 patents in stem cell culture, refractive corneal implants and novel inserters for DSAEK surgery. He was instrumental in bring ARVO to Asia in the form of Asia-ARVO, has conducted over 80 international teaching courses, and has also trained 23 corneal fellows from 13 countries from 4 continents. Professor Tan is the recipient of over 20 awards, which include the APAO 2001 De Ocampo Award, the AAO 2006 Distinguished Achievement Award, the ISRS/AAO 2009 Casebeer Award, the Saudi Ophthalmological Society 2010, Gold Medal, the Australia and New Zealand Corneal Society 2011 Doug Coster Award, and the Canadian Society of Ophthalmology 2011 W. Bruce Jackson Award. He is currently President Elect of The Cornea Society, and President of the Asia Cornea Society (ACS) and the Association of Eye Banks of Asia (AEBA). In 2012, he will be appointed as the President of the Cornea Society, the Society’s first international president.
Xin TANG, China|
Prof. Xin TANG, MD, is president of Tianjin Eye Hospital, dean of Tianjin Eye Institute, doctoral candidate tutor, vice dean of the Cataract Group of the Chinese Ophthalmological Society, chairman of the Tianjin Ophthalmology Society, expert member of the Chinese Ophthalmology Society, member of the standing committee and secretary of the Chinese Medical Doctor Association, vice dean of the national committee of blindness prevention technology, member of the American Society of Cataract and Refractive Surgery, and member of the World Society of Ophthalmologists.
He is deputy editor-in-chief of the Chinese Journal of Ophthalmology and a member of the editorial board of the Chinese Journal of Ophthalmology, Chinese Journal of Experimental Ophthalmology, Chinese Journal of Optometry and Visual Science and Ophthalmology.
Prof. Tang is the chief surgeon in the Cataract Center of Tianjin Eye Hospital. He has nearly 30 years of rich experience in clinical and basic research and is committed to providing quality patient-centered eye care services. He has performed over tens of thousands of cataract surgeries.
He is in charge of many scientific research projects and teaching programs and has received many scientific and technological awards. He holds one patent and has published four books and 113 peer-reviewed research papers. He is a guest professor at NOVA Southeastern University and honorary professor at Hong Kong Polytechnic University and the University of Hong Kong. He was awarded the APACRS Certified Educator. He also received the Chinese Ophthalmological Society Award and the Asia-Pacific Academy of Ophthalmology Outstanding Service in Prevention of Blindness Award for his contributions to education and prevention and management of blindness.
Marie-José TASSIGNON, Belgium
Tassignon Marie-José, MD, PhD, FEBO, is full professor of ophthalmology at Antwerp University, Faculty of Medicine and Chair of the Department of Ophthalmology at Antwerp University Hospital since 1991. She is member of 8 national societies and board member of 6. She is member of 18 international societies and board member of 6. She was invited speaker in many national and international societies, promotor of 6 PhD theses and published 215 articles in peer-reviewed journals. She is author of 6 patents, inventions related with cataract surgery and developed ophthalmic instruments in collaboration with the industry. She received several awards from which the Binkhorst Medal Lecture (ESCRS, Vienna, 2011).
Hugh TAYLOR, AUSTRALIA|
Professor Hugh R Taylor AC undertook his training in medicine and ophthalmology at the University of Melbourne. He worked with the late Fred Hollows as Associate Director of the National Trachoma and Eye Health Program and completed his Doctorate of Medicine on Aboriginal Eye Health. This work among Indigenous Australians influenced his career and his work to improve vision in the world's most disadvantaged populations, reaching beyond Australia including Mexico, Liberia, Tanzania, Nepal, Vietnam and Eritrea.
He spent 1977 to 1990 in the United States and held chairs in the Schools of Medicine and Hygiene and Public Health at Johns Hopkins University in Baltimore. He was the associate director of the International Center for Preventive Ophthalmology at the Wilmer Eye Institute.
He returned to the University of Melbourne in 1990 as Ringland Anderson Professor of Ophthalmology – the chair named for his grandfather – and Head of the Department of Ophthalmology. In 1996 he founded the Centre for Eye Research Australia, now one of Australia's leading eye research institutes. In 2008 he took up the Harold Mitchell Chair of Indigenous Eye Health in the Melbourne School of Population and Global Health at the University of Melbourne and was appointed a Melbourne Laureate Professor in 2011.
As a leading corneal surgeon he has also been heavily involved in teaching and hospital work, teaching a generation of ophthalmologists the importance of clinical care with both a population and research perspective, invaluable lessons they will apply to the rest of their medical careers. His clinical work focused particularly on corneal transplantation and eye banking, external disease and refractive surgery which he pioneered in Australia.
Professor Taylor is recognised as a clinician-scientist whose research has included laboratory science and clinical research. His primate model for trachoma confirmed the importance of recurring Chlamydia infection of the eye. Other contributions include work on ivermectin as chemotherapy for onchocerciasis (river blindness), the link between ultraviolet radiation exposure and cataracts, cigarette smoking and eye disease and contributions to the control of trachoma.
Hugh Taylor has served as a consultant to many agencies, governments, and foundations, and has been a member or chair on numerous advisory committees. He is President of the International Council of Ophthalmology and the former Regional Chair and Vice President of the International Agency for the Prevention of Blindness. He has been recognised with 18 international awards including the 2015 Jose Rizal Medal from the Asia Pacific Academy of Ophthalmology, the Lifetime Achievement Award from the American Academy of Ophthalmology, the Research Australia Lifetime Achievement Award, the Royal Australian and New Zealand College of Ophthalmologists Gold Medal and the Helen Keller Prize for Vision Research. In 2001, he was made a Companion in the Order of Australia in recognition of his multiple achievements: to the prevention of river blindness, to academia, and to eye health in indigenous communities. In 2013 he was appointed a member of the expert advisory panel of the Queen Elizabeth Diamond Jubilee Trust.
The most widely published ophthalmologist in Australia, with over 600 peer-reviewed publications and multiple books, his research and teaching has informed clinical practice and led to the design and delivery of community eye health care programs. His population-based studies in Australia have defined the agenda for eye research and for the implementation of eye care delivery programs for Aboriginal Australians.
Clement THAM, Hong Kong |
Clement C.Y. Tham is Professor of Department of Ophthalmology and Visual Sciences at The Chinese University of Hong Kong, Chief-of-Service of Hong Kong Eye Hospital, and formerly the Chief-of-Service of Ophthalmology at Prince of Wales Hospital. Prof. Tham is the Ophthalmology Editor of Hong Kong Medical Journal, and previously the Editor-in-Chief of Hong Kong Journal of Ophthalmology. Prof. Tham has peer-reviewed scientific manuscripts for 13 international journals, including The Lancet. Prof. Tham is the Deputy Secretary-General of Asia-Pacific Academy of Ophthalmology (APAO), and is also the Chair of the APAO Congress Committee. He is Chair of the Scientific Program Committees of The 27th APAO Congress 2012 in South Korea, The Inaugural Congress of the Asia-Pacific Glaucoma Society 2012 in Indonesia, and The 28th APAO Congress 2013 in India. For his work in the prevention of blindness, Prof. Tham was awarded the inaugural Nakajima Award by the Asia Pacific Academy of Ophthalmology (APAO) in 2005. In the same year, Prof. Tham was one of the awardees of the Ten Outstanding Young Persons Award in Hong Kong. Prof. Tham received the Achievement Award from the American Academy of Ophthalmology (AAO) in 2008, and the Achievement Award from the Asia-Pacific Academy of Ophthalmology (APAO) in 2010. Prof. Tham has also received numerous other awards in recognition to his contributions to research and teaching in the field of glaucoma.
Sharon TOW, Singapore
Dr Tow graduated from the University of Sydney. Following training in ophthalmology in Edinburgh and Singapore, she completed a one-year fellowship in Neuro-ophthalmology under the mentorship of Prof Neil Miller at the Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore. On her return to the Singapore National Eye Centre, she helped to consolidate the Neuro-ophthalmology service, and since 2006, has been the head of this service. Dr Tow is actively involved in the teaching of residents and medical students, and is an examiner for the Singapore College of Ophthalmology as well as the Royal College of Surgeons, Edinburgh. She has been an invited speaker at national, regional and international meetings. She is also involved in research projects at her center and reviews regularly for various ophthalmology journals.
David T. TSE, USA
Dr David T. Tse is the Professor of Ophthalmology and head of the Ophthalmic Plastic, Orbital Surgery and Oncology Service at the Bascom Palmer Eye Institute in Miami, Florida. He currently holds the inaugural Dr Nasser Ibrahim Al-Rashid Distinguished Chair in Ophthalmic Plastic, Orbital Surgery and Oncology. Dr Tse’s clinical interests include the full spectrum of lacrimal, eyelid and orbital reconstructive surgeries due to disease or injury, as well as aesthetic and rejuvenative surgeries. His clinical research efforts center on innovative ways to treat extensive skin cancers and lethal orbital malignancies. In the laboratory, Dr Tse’s efforts are directed at developing an animal model to assess the molecular and cellular sequelae of experimental traumatic optic nerve injury and to identify novel therapeutic strategies. His other area of research concentration is the identification of orbital tumor cell markers as prognostic indicators for targeted therapy. He is a member of the Editorial Board for the American Journal of Ophthalmology and the Ophthalmic Plastic and Reconstructive Surgery Journal. His writings include The Color Atlas of Ophthalmic Surgery: Oculoplastic Surgery, and over 100 scientific articles and 50 book chapters. He was a director of the American Board of Ophthalmology, and Dr Tse’s oculoplastic peers named him to the Woodward/White’s The Best Doctors in America and included him among America’s Top Doctors.
Kazuo TSUBOTA, Japan
Professor Kazuo Tsubota is Chairman of the Department of Ophthalmology at Keio University School of Medicine, his alma mater, in Tokyo, Japan. An internationally recognized dry eye specialist, Professor Tsubota has been working on the pathogenesis and treatment of dry eye. One focus of his research is improving the ocular surface and proper function of vision through assessing functional visual acuity. Other research projects include ocular surface reconstruction, regeneration of the cornea, lacrimal gland, immunology of Sjogren’s syndrome, dry eye, and wound healing of refractive surgery. He heads an active dry eye research group as well as an active refractive group in Japan, resulting in publishing more than 500 peer reviewed articles, including, New England Journal of Medicine, The Lancet, Proceedings of the National Academy of Sciences, Journal of Clinical Investigation, Journal of Immunology, FASEB Journal, Ophthalmology and the American Journal of Ophthalmology. He was the first Japanese recipient of the American Academy of Ophthalmology Honor Award in 1994. Prof. Tsubota holds editorial positions on several ophthalmic journals as well as being a regular reviewer of ophthalmic journals.
Abhay VASAVADA, India
After completing his FRCS in 1980 from the Royal College of Surgeons of England, Dr Abhay Vasavada specialized in cataract surgery. Eight years into his practice at Raghudeep Eye Clinic, he set up Iladevi Cataract & IOL Centre in 1991 devoted exclusively to cataract research and in particular to congenital cataract in children. As a director of Raghudeep Eye Clinic and Iladevi Cataract & IOL Research Centre, he has awarded more than 100 fellowship to the ophthalmologists from all over the world. To his credit, more than 135 publications are listed in various national and international journals. He has been invited to perform live surgery demonstration across the globe in countries like USA, Germany, Italy, Hungary, Saudi Arabia, Gulf-countries, entire Asia Pacific region including China And Australia. He is a distinguished member of different ophthalmic societies from all over the globe. He has been a recipient of best researcher award and Dr B.C. Roy National Award by Honorable President Dr K.R. Narayanan in 1997. In 2002 he was the recipient of 1st Asia Pacific Association of Cataract & Refractive Surgeons (APACRS) Award for Best Educator in Asia Pacific Region. He has been a recipient of American Academy of Ophthalmology’s Achievement Award, 2005. He has also been awarded the Arthur Lim Oration by the Asia-Pacific Association of Cataract and Refractive Surgeons (APACRS) for the year 2010. He is the first Indian to be awarded Binkhorst Medal Lecture by the American Society of Cataract & Refractive Surgeons (ASCRS) in 2011. He was selected as one of the “Top Fifty Opinion Leaders” in 2005 for his Outstanding Contribution and Leadership in the field of cataract surgery, a survey taken by a “Journal of Cataract & Refractive Surgery Today”. For last few years he is also heading & supervising research related to cataract development & management in children as well as adults. His ultimate goal is to keep providing highest quality of cataract management and solve some of the problems facing children and young adults.
Ningli WANG, China
Professor Ningli Wang is the Director and the vice president of the eye center of Beijing Tongren Hospital, which is one of the two largest eye centers in China and provides a comprehensive and seamless Ophthalmic Service for 600,000 outpatients and 54,000 surgeries annually. World-class scholarship enhanced by hard gained clinical knowledge helped Wang Ningli gain the position of director at the internationally-renowned eye center of Beijing Tongren Hospital, back in 2002. As a key educator and the President-Elect of Chinese Ophthalmological Society, he devoted himself into ophthalmic practice, teaching, training, blindness prevention and academic research in China and beyond. His past accomplishments and contributions produced significant impact on Chinese Ophthalmology and Asia-pacific region. Prof. Wang is a foresight leader, who serves for a better direction of Chinese Ophthalmology development, a dedicated educator, who give benefits to Chinese Young ophthalmologists, an excellent communicator, who bridges the Chinese ophthalmology with Asia-pacific region and beyond, A passionate student, who always thirst for the unknown and respects for the senior researcher, a merciful physician, who devoted into caring for patients and blindness prevention. A breakthrough came in early 2009 when Wang and his team came up with their “trans-lamina cribrosa pressure difference theory” on open-angle glaucoma (data published in Ophthalmology 2010;117:259–266) . The research result was first published during the Association for Research in Vision and Ophthalmology Conference, held in Florida, US, in April 2009. Wang’s American professor from the Shiley Eye Center was impressed, calling it “a milestone paper”. Prof. Wang is the Chinese Ophthalmological Society, President-Elect and Chairman of Chinese Ultrasound Technology Association, Board Member of Asia Oceanic Glaucoma Society and South-east Asia Glaucoma Interested Group. Prof. Wang has published more than 300 articles including 100 SCI journal articles and serves as the society editor of International Glaucoma Review, editorial board member of a few international journals including Ophthalmology, Ophthalmic Research, British Journal of Ophthalmology. He has received a number of prestigious awards including “Outstanding Specialist Award from State Council of China”, APAO “Achievement award” and “Arthur Lim award”.
Robert N. WEINREB, USA
Robert N. Weinreb, M.D.is the Chairman and Distinguished Professor of Ophthalmology, Morris Gleich Chair, Director of the Shiley Eye Center, and the Director of the Hamilton Glaucoma Center at the University of California, San Diego. A graduate of the Harvard Medical School, Dr Weinreb is a clinician, a surgeon and a scientist. He has been named to every edition of Best Doctors in America since its inception, and patients from throughout the world seek his medical and surgical expertise. Dr Weinreb also is a prolific researcher and teacher. He has authored more than 1400 scientific publications. His current research interests include aging and the eye, all aspects of glaucoma, neuroprotection of the optic nerve and retina, and the translation of stem cell biology and gene therapy to eliminate blindness. Dr Weinreb has served as President of some of the most respected organizations within the profession including the Association for Research in Vision and Ophthalmology (2002-2003), the World Glaucoma Association (2004-2006) and the American Glaucoma Society (2007-2009). He is President of the American Glaucoma Society Foundation and President-Elect of the Pan American Glaucoma Society. Dr Weinreb also is Chair of the Global Glaucoma Consensus Initiative of the World Glaucoma Association. He has trained more than 120 post-doctoral Fellows in Glaucoma, many of whom hold distinguished academic positions throughout the world..
Feng WEN, China|
Prof. Wen is a specialist in medical retina, and his expertise lies in the eye images and macular diseases. He graduated from Sun Yat-sen University (SUMS), and obtained his PhD in Ophthalmology. His awards include the Ministry of Education Science and Technology Progress Award, the Chinese Medical Science Prize, and the Guangdong Science and Technology Award. He has published more than 40 SCI-indexed peer-reviewed articles as the first author or corresponding author. He has also served as Editor-in-Chief of 3 books.
Prof. Wen serves as the Director of Macular Clinic at the Zhongshan Ophthalmic Center, SUMS and the PI of State Key Laboratory of Ophthalmology. Furthermore, he is the President of Guangdong Society of Fundus Image, Vice-President of Guangdong Society of Traditional Chinese and Western Medicine in Ophthalmology, Vice President of the Guangdong Society of Traditional Chinese Medicine in Ophthalmology and a Committee member of the Chinese Fundus Disease Society.
Tien Yin WONG, Singapore
Professor Tien Y Wong is currently Chairman, Department of Ophthalmology, National University of Singapore and National University Hospital, and Director of the Singapore Eye Research Institute. Prof Wong is retinal specialist, balancing clinical practice in macular and retinal diseases such as diabetic retinopathy, age-related macular degeneration and retinal vein occlusion with a broad-based research program focused on the epidemiology of Asian retinal diseases, and on the use of retinal imaging to predict cardiovascular risk. He has published more than 500 peer-reviewed papers, including papers in the New England Journal of Medicine, the Lancet, the Journal of the American Medical Association (JAMA), and Nature. Prof Wong is the Executive Editor of the American Journal of Ophthalmology, and on Editorial Board of IOVS, Ophthalmic Epidemiology, Ophthalmologica and Diabetes Care. Prof Wong has been recognized internationally and nationally with numerous awards, including the Sandra Doherty Award from the American Heart Association, the Alcon Research Institute Award, the Novartis Prize in Diabetes, Australian Society of Medical Research AMGEN Medical Research of the Year Award, the Asia Pacific Academy of Ophthalmology De Ocampo Award, the Singapore Translational Researcher Award (STaR), the National Outstanding Clinician-Scientist Award and the President’s Science Award.
Victoria WONG, Hong Kong
Dr Victoria Wong is an anterior segment eye specialist specializing in cornea and external eye diseases and lens surgery. She is currently Consultant Ophthalmologist of Hong Kong Eye Hospital, Honorary Clinical Associate Professor at the Department of Ophthalmology & Visual Sciences of The Chinese University of Hong Kong, Honorary Visiting Professor of Joint Shantou International Eye Center of Shantou University (DOVS-CUHK), Hong Kong, Subspecialty Fellowship Training Program Coordinator of Cornea & External Eye Diseases Subspecialty of DOVS-CUHK and a Member of the Coordinating Committee in Ophthalmology of the Hospital Authority of Hong Kong.
Lin-Chung WOUNG, Chinese Taipei
Dr Woung, MD, DMSc, is currently the deputy superintendent for Taipei City Hospital and the President of Taiwan Academy of Ophthalmology. He has taken on key positions in the Ophthalmologic Society in Taiwan for the past 14 years, and has been the director of society since year 1993. Academically, he is the recruiter for the Editorial & Publication Committee of the Ophthalmologic Society of Taiwan, the chief editor of the Taiwan Journal of Ophthalmology and the Taipei City Medical Journal, He has been the reviewer of the Journal of Asian Neuro-Ophthalmology Society and the Journal of Ophthalmology…etc. He was also the vice president of Asian Neuro-Ophthalmology Society for 2008, and is now working on the International Neuro-Ophthalmology Symposium. He has won the Distinguished Service Awards in APAO 2010 and the Outstanding Service in Prevention of Blindness Award in APAO 2011. Dr Woung is an associate professor accredited by the Department of Education Taiwan since 1995, and holds various teaching roles in 5 national medical schools including the National Taiwan University College of Medicine. He keeps a companionable relationship with all of the above organizations and his support and dedication to the Ophthalmology Society in Taiwan is beyond question.
Lixin XIE, China
Lixin Xie, MD, member of Chinese Academy of Engineering, serves as professor of ophthalmology and director of Shandong Eye Institute (Qingdao, China). Prof. Xie is engaged in the basic research and clinical work of cornea and cataract. As a leader in the field of cornea in China, he brought forward the theory of different fungal species showing horizontal or vertical growth patterns in corneas and pushed lamellar keratoplasty to treat fungal keratitis. He also developed intraocular cyclosporine A delivery system, with independent intellectual property rights in China, for prevention of immune rejection after keratoplasty. Moreover, he was among the early ones who introduced cataract phacoemulsification to China. Prof. Xie has not only won 16 provincial and national Prizes for Progress in Science and Technology, but also published three authored books, 28 compiled or translated books, and 495 papers. Furthermore, he is doctoral program supervisor of Peking University, Zhejiang University, Wuhan University, Huazhong University of Science and Technology, and Qingdao University. Among his honors are the Golden Key Award of Chinese-American Ophthalmological Society (2004), Outstanding Achievement Award of Chinese Ophthalmological Society (2006), American Academy of Ophthalmology’s Achievement Award (2008), and Arthur Lim Award of Asia-Pacific Academy of Ophthalmology (2009).
Jason YAM, Hong Kong
Jason Yam, MBBS(HKU), MPH (HKU), FRCS(Edin), FCOphth (HK), FHKAM (Ophth), is currently Assistant Professor at the Department of Ophthalmology and Visual Sciences of the Chinese University of Hong Kong, Hong Kong, and Associate Professor of Joint Shantou International Eye Centre of the Chinese University of Hong Kong and Shantou University. He is the Academic Coordinator of the Pediatric Ophthalmology Service in the Hong Kong Eye Hospital.
Dr. Yam received overseas training in Pediatric Ophthalmology at Great Ormond Street Hospital, UK, and Strabismology with Prof. David Guyton at Johns Hopkins Hospital, USA. He also completed an international fellowship with Prof. Kenneth Wright in Los Angeles. Dr Yam serves as a Council Member in the Asia-Pacific Strabismus and Paediatric Ophthalmology Society, and in the Hong Kong Ophthalmological Society. He is active in training and teaching, and is currently the Coordinator of Undergraduate Medical Teaching at the Chinese University of Hong Kong.
He has more than 20 publications and has co-authored one book. He has delivered more than 40 presentations and invited lectures in international conferences. He also serves as an editor in the Hong Kong Journal of Ophthalmology, and reviewer of 10 international journals. He has received a number of awards, including Hong Kong Society of Community Medicine Prize, Dr Timothy Kai-Ching Liu Memorial Fund Award, Distinguished Young Fellow in HKAM 2013, APAO Yasuo Tano Travel Grant 2014, and the WOC Travel Grant 2014. He also undertakes the APAO Leadership Development Program.
Peizeng YANG, China
Prof. Peizeng Yang, of the First Affiliated Hospital of Chongqing Medical University, China, is engaged in studies on the diagnosis and treatment of uveitis and the mechanisms involved in this disease. He has made contributions to the improvement of diagnosis and treatment of Vogt-Koyanagi-Harada syndrome, Fuchs’ syndrome and Behcet’s disease, as well as the understanding of the mechanisms of uveitis. His work has been supported by more than 30 research grants totalling 30 million renminbi. Prof. Yang has more than 100 peer-reviewed papers in international journals and three Chinese books on uveitis. He is an international representative in the Council of the International Ocular Inflammation Society, a founding executive member of the Asia-Pacific Intraocular Inflammation Study Group, a member of the International Uveitis Study Group, and a council member of the International Society for Behcet’s Disease.
Ke YAO, China
Dr Yao got his doctor degree in ophthalmology from Shanghai Second Medical University in1988. From 1988 to 1990, he had been in University Eye Clinic Basel, Basel , Switzerland , for two years of postdoctoral research and won the Alfred-Vogt Prize. Dr Yao is specialized in ocular anterior segment diseases. His career has been dedicated to the research, teaching and practice of advanced techniques in cataract prevention and treatment. He is a skillful surgeon especially for cataract and glaucoma surgery. Dr Yao has not only performed over thirty thousand successful small incision phacoemulsification with intraocular lens implantation, but he is also an experienced pioneer on microincision phacoemulsification. Working with the newest techniques, Dr Yao is training the next generation of eye surgeons.
Chee Chew YIP, Singapore
Dr Yip Chee Chew, MBBS, MMed(Ophth), FRCS(Edin), FAMS(Ophth), graduated from the National University of Singapore with a Bachelor of Medicine and Bachelor of Surgery in 1981 and a Master of Medicine (Ophthalmology) in 1998. He is a Fellow of the Royal College of Surgeons of Edinburgh and the Academy of Medicine, Singapore (AMS). Under the Singapore Health Ministry scholarship, he did his two Oculoplastics fellowships at the University of Cincinnati and University of California, Los Angeles (UCLA) from 2001 to 2003. During the latter, he received the Ann C Rosenfield Fellowship Fund Award. He is the department head and senior consultant at Khoo Teck Puat Hospital and Head, Oculoplastics service at National Healthcare Group (NHG) Eye Institute. He is the deputy chairman of the NHG Ethics Board. He is elected as the President of the Asia Pacific Society of Ophthalmic Plastic and Reconstructive Surgery and the secretary of the College of Ophthalmologist, AMS in 2010. He has published more than 40 peer review articles and has written 2 Oculoplastic book chapters. He received the 2008 American Academy of Ophthalmology Achievement Award in recognition of his dedication to ophthalmic education. He is appointed as the Oculoplastics section editor of the Asia Pacific Journal of Ophthalmology in 2011.
Alvin YOUNG, Hong Kong
Dr Young is currently the deputising Chief of Service & the Head of Corneal & External Eye Disease Service at the Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital and Alice Ho Miu Ling Nethersole Hospitals. He is an Honorary Clinical Associate Professor of the Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong & an Honorary Visiting Professor of STU/CUHK Joint Shantou International Eye Centre. Dr Young has over 50 peer reviewed publications & has delivered over 100 courses, lectures and presentations at major international ophthalmic scientific meetings. Dr Young has been serving as a reviewer for more than 15 peer reviewed journals and was the recipient of the Asia-Pacific Academy of Ophthalmology Congress Distinguished Service Award in 2009. He served as a scientific coordinator for the World Ophthalmology Congress 2008 and APAO Congresses (2009, 2010, 2011 and 2012) Corneal Programs.
Hunter YUEN, Hong Kong|
Dr. Hunter Yuen graduated from the Chinese University of Hong Kong in 1995 with a First of Medicine (Gold Medal) award. He is a consultant and coordinator of the Orbital and Oculoplastic Surgery at Hong Kong Eye Hospital. He did his fellowship at Johns Hopkins University in 2003. He has authored more than 60 peer-reviewed international publications and several book chapters and has delivered numerous lectures at international meetings.
His awards include Best Oral Presentation at the 2001 Hong Kong Annual Scientific Meeting, Best Oral Presentation at the 4th International Symposium of Ophthalmology and one of the best posters at the American Academy of Ophthalmology 2005 Annual Meeting. Dr. Yuen was elected as one of the Ten Young Outstanding Persons in 2007 and Hong Kong Outstanding Volunteer in 2011. He has also been awarded the Asia-Pacific Academy of Ophthalmology (APAO) Yasuo Tano Travel Grant, APAO Achievement Award and APAO Distinguished Service Award.
Dr. Yuen is actively involved in numerous nongovernmental organizations and charity work. He is also vice president of the Asia Pacific Society of Ophthalmic Plastic and Reconstructive Surgery, president of the Hong Kong Society of Ophthalmic Plastic and Reconstructive Surgery and honorary professor at Shantou University.
Marco ZARBIN, USA|
Dr. Marco Attilio Eugenio Zarbin, MD, PhD, FACS, graduated from the Johns Hopkins University School of Medicine (Medical Scientist Training Program, αθα). Dr. Zarbin completed resident and fellowship training (vitreoretinal surgery and medical retina) at the Wilmer Ophthalmological Institute and was an assistant chief of service there. Dr. Zarbin is chair of the Institute of Ophthalmology and Visual Science, Rutgers-New Jersey Medical School and chief of ophthalmology at University Hospital in Newark, NJ. He is a professor of ophthalmology and neuroscience and is the Alfonse A. Cinotti, MD/Lions Eye Research Chair. Dr. Zarbin is co-director of the Ocular Cell Transplantation Laboratory.
Dr. Zarbin has published 198 peer-reviewed papers and editorials, 96 book chapters, 184 abstracts, one book on age-related macular degeneration, one book on stem cell therapy for degenerative retinal disease and one book on the management of diabetic retinopathy. Dr. Zarbin is a NEI-NIH‒funded investigator.
Dr. Zarbin is a vice chair of the Scientific Advisory Board of the Foundation Fighting Blindness and is an ex officio member of the National Advisory Eye Council of the National Institutes of Health. He is also a member of the American Ophthalmological Society, Academia Ophthalmologica Internationalis, the Retina Society, the Macula Society, the Gonin Society and the ASRS.
|Benny ZEE, Hong Kong
Prof Benny Zee is Assistant Dean of Research for the Faculty of Medicine and also Professor and Director of the Centre for Clinical Research and Biostatistics and Head of the Division of Biostatistics in the JC School of Public Health and Primary Care, Chinese University of Hong Kong (CUHK), and Director of Clinical Trials and Biostatistics Lab in the CU Shenzhen Research Institute (SZRI). He holds honorary appointments in the Department of Clinical Oncology and the Department of Statistics of CUHK. He is also the Chairman of the Joint CUHK-NTEC Clinical Research Ethics Committee since 2006. Professor Zee obtained his Ph.D in Biostatistics from the University of Pittsburgh USA in 1987. He then joined the National Cancer Institute of Canada Clinical Trials Group as Senior Biostatistician, and faculty member in the Department of Community Health and Epidemiology and the Department of Mathematics and Statistics of Queen’s University Canada from 1987-2001. He remains as Adjunct Professor with Queen’s University after he joined CUHK and is actively promoting international academic activities and collaborations.
Professor Zee has strong interest in various aspects of multi-center clinical trials, including statistical methods, data management, drug and medical device development. On the methodological side, he is active in Biostatistics research, especially in the area of clinical trials design, bioinformatics, quality of life, data & safety monitoring and other statistical issues. He has experience in the development of efficient data management procedure using advanced computer technology for “big data”, plus ample experience in working with industry to design and to carry out clinical trials that satisfy both academic interest and industry objectives. He has tremendous experience in the development of hospital infrastructure such as Ethics Committee, GCP Centre and quality assurance team to carry out clinical research in hospitals that satisfies regulatory and international requirements. He is also active in medical devices development such as “automatic retinal imaging analysis system (ARIAS)” and serves in the Centre for Entrepreneurship of CUHK. He had published more than 170 international peer reviewed journal articles and serves in various committees including advisory committees for drug development and data & safety monitoring committees for international drug trials.
Fengju ZHANG, China|
Fengju Zhang, MD, PhD, is a professor at the Eye Center of Beijing Tongren Hospital affiliated with Capital Medical University. She is vice president of the Chinese Society of Optometry, member of Beijing Ophthalmological Society and academic leader of Beijing 215 Talent Fund. She is a member of the editorial boards of the Chinese Journal of Ophthalmology; Chinese Journal of Optometry, Ophthalmology and Visual Science; Chinese Medical Journal; Chinese Journal of Practical Ophthalmology; and Asia-Pacific Journal of Ophthalmology.
She graduated from China Medical University in 1992 with her doctoral degree. In total, she received medical training from 1983 to 1992 through general medicine training for her bachelor's degree, followed by general ophthalmic training for her master's and doctoral degrees at China Medical University. She finished her postdoctoral research on UV and cataract at St. Erik's Eye Hospital affiliated with the Karolinska Institute in Sweden, sponsored by the China Ministry of Education, in 1999.
Prof. Zhang has performed cataract phacoemulsification with IOL implantation from 1995 and corneal refractive surgery (LASIK) since 1996. She has performed phakic IOL implantation for high myopia since 2004. With full clinical experiences in the management of refractive error and cataract, she has devoted herself to ophthalmic practice, teaching, training, blindness prevention and academic research in China. Her current research, supported by the General Program of the National Natural Science Foundation of China, Beijing Natural Science Foundation and Beijing Education Committee Foundation, is concentrated on myopia prevention and treatment.
Prof. Zhang has published a series of academic papers in her research field and has contributed to academic books such as Refractive Surgery, Mastering the Techniques of IOL Calculations, Mastering Advanced Surface Ablation Techniques, Practical Corneal Refractive Surgery Procedure and Femtosecond Laser Corneal Refractive Surgery.
Kang ZHANG, USA|
Kang Zhang, MD, PhD is Professor of Ophthalmology, Chief of Ophthalmic Genetics at University of California San Diego. Zhang obtained his M.D. with Magna Cum Laude honors from Harvard Medical School and MIT joint MD program and his PhD in genetics from Harvard University. He completed his residency in ophthalmology at Wilmer Eye Institute at Johns Hopkins University and his retina fellowship at University of Utah. He was a faculty at Johns Hopkins University, Cleveland Clinic Foundation, University of Utah.
Dr. Zhang's clinical and research focuses are on novel disease gene targets and treatment, gene and stem cell based therapies in age related macular degeneration, diabetic retinopathy,and inherited retinal degeneration.
Dr. Zhang is bi-lingual in Chinese and he has numerous grants from the National Institute of Health, and other foundations. Dr. Zhang has published or co-authored more than 100 peer reviewed manuscripts in top journals - covering a wide range of topics in genetics, molecular biology, stem cell, and clinical trials in ophthalmology.
Minghzhi ZHANG, China|
Prof Mingzhi has been working in Ophthalmology for more than 30 years. Specialising in cataract, glaucoma and optometry, she is one of the earliest ophthalmologists in China to perform phacoemulsification and refractive cataract surgery. Her research, such as combining surgery for glaucoma with cataract and building surgical treatment models, was well-received by the international ophthalmic community. Recently, Prof Zhang has focused her works on mapping of disease-causing genes of congenital cataract and susceptibility genes of glaucoma and high myopia. She has conducted six nationwide research projects, two International cross-cutting projects and three provincial research projects in recent years. She has published 131 papers, 61 of which are published in international peer-reviewed SCI journals.
Prof Zhang currently serves as an Editorial Board Member of the Chinese Journal of Ophthalmology, the Chinese Journal of Optometry, Ophthalmology and Visual Science, the Chinese Journal of Experimental Ophthalmology, the Chinese Journal of Practical Ophthalmology, and the Chinese Journal of Ophthalmology and Otorhinolaryngology. She is also an editor of the teaching material for Ophthalmology of Higher Education, the deputy chief editor of the teaching material for Eye Diseases in Optometry of Higher Education. She is also a committee member of the Chinese Ophthalmological Society, the Ophthalmologist Society of Chinese Doctoral Association, an executive member of the Ophthalmologic Society of China Medical Women's Association, the deputy director of Ophthalmology Society of Guangdong Medical Council, and the Guangdong Ophthalmological Society.
Dr. Ping Zhang is an associate professor and director at the pathological department, Zhongshan Ophthalmic Center, Sun Yat-sen University. She has been working at the Zhongshan Ophthalmic Center since 1995. She obtained her PhD. degree in ophthalmology at the Zhongshan Ophthalmic Center in 1995 (supervisor: Prof. Guanguang Feng). She gained the National Natural Science Foundation of China in 2003. She has published more than 50 peer-reviewed articles and four book chapters. She is the recipient of the Science and Technology Progress (third prize) in the Guangdong province as a coauthor in 2001.
Qingjiong ZHANG, China|
Prof. Qingjiong Zhang is director of the Eye Research Institute and vice president of Zhongshan Ophthalmic Center (ZOC), Sun Yat-sen University. He also serves as deputy director of the State Key Laboratory of Ophthalmology. He received his medical education at Tongji Medical University (1980-1985) and his training in ophthalmology at Sun Yat-sen University of Medical Sciences (1985-1990). He became a full-time staff member at ZOC in 1990 and was promoted to full professor in 1996. Currently, he is a consultant ophthalmologist for pediatric and genetic eye diseases and a principal investigator for ophthalmic molecular genetics at ZOC.
From 1993-1995, Prof. Zhang studied retinoblastoma with Prof. Kensei Minoda at Teikyo University Ichihara Hospital, Japan as a postdoctoral fellow. From 2001-2003, he learned the molecular basis of circadian rhythmicity in the retina with Prof. Joseph C. Besharse at the Medical College of Wisconsin as a visiting scientist. From 2013-2015, he received training in ophthalmic molecular genetics from Dr. J. Fielding Hejtmancik at the National Eye Institute, National Institutes of Health, USA as a research fellow.
Prof. Zhang's major interest focuses on the identification of genetic defects for hereditary eye diseases and their associated phenotypes. Such studies have involved early-onset high myopia, retinitis pigmentosa, Leber congenital amaurosis, cone or cone-rod dystrophy, optic neuropathy, glaucoma, congenital cataract, nystagmus, etc.
Xiulan ZHANG, China|
Prof. Xiulan Zhang, MD, PhD, glaucoma specialist, is currently the vice director of the Glaucoma Department, director of the Clinical Research Center and director of the Institution of Drug Clinical Trials at the Zhongshan Ophthalmic Center in Guangzhou. She is also a member of the Association for Research in Vision and Ophthalmology and the Chinese Medical Association's Chinese Ophthalmological Society. She has served as secretary of the Chinese Glaucoma Society and as a council member of the Chinese Neuro-Ophthalmology Society.
She has published more than 190 articles in international and Chinese peer-reviewed journals, six book chapters and one book, Illustrated Clinical Diagnosis and Treatment of Glaucoma (September 2014). She has received 21 scientific grants including four from the National Natural Science Foundation of China. She serves as an editorial board member of more than 10 ophthalmology journals and a reviewer for more than 10 peer-reviewed journals including Investigative Ophthalmology and Visual Science, PLoS One, British Journal of Ophthalmology, Molecular Vision and Journal of Ocular Pharmacology and Therapeutics. She has received a number of prestigious awards including the National Science and Technology Progress Award. In light of her research on anatomical dysfunction in glaucomatous eyes and how surgical intervention can help, she was listed as one of the 100 most influential people in ophthalmology in 2014.
Kanxing ZHAO, China
Editor-in-Chief of the Chinese Journal of Ophthalmology and President of the Chinese Ophthalmological Society.
Prof. Kanxing Zhao is the Director and Professor of Ophthalmology at the Tianjin Eye Hospital and Institute and Vice President and Dean of the Graduate Faculty, Tianjin Medical University.
Prof. Zhao obtained his bachelor's degree in medicine at the Tianjin Medical College and his M.D., Ph.D. at the Peking Medical University. He was a fellow under two of the most prominent strabismologists in China, Dr. Yushi He and Dr. Jiaqi Liu. He also had clinical training at Kobe University, Kobe, Japan and at Indiana University in the US.
As Director of the Tianjin Eye Hospital and Research Institute, Prof. Zhao has led an academic institution of over 400 faculty and staff, 120 of whom are ophthalmologists. The hospital has an outpatient attendance of 500,000 patients per year and is one of the largest and most modern hospitals in the region.
Prof. Zhao's expertise is in the diagnosis and management of pediatric ophthalmology and genetic eye diseases as well as in strabismus and amblyopia. Clinically, he is best known for his expertise in complicated strabismus cases, vertical strabismus and congenital nystagmus.
Over the last two decades, Prof. Zhao's research interests have focused on genetic eye diseases. He has studied the pathogenetic mechanisms of retinitis pigmentosa and mapped a novel locus and RP33 in Chinese families with autosomal dominant retinitis pigmentosa. His work was published in the American Journal of Human Genetics. Because of his research achievements, Prof. Zhao has been supported by a series of grants from the National Natural Science Foundation, the Ministry of Education and Health, and the Tianjin Natural Science Foundation. He has 220 Chinese publications and 34 publications in English.
As the Chief Physician of the Tianjin Eye Hospital and Research Institute, Prof. Zhao has made significant contributions to graduate education as evidenced by his teaching hundreds of residents, 49 students in the Master's medical program and 48 students in the doctoral program in medicine.